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Macrophage phagocytosis of apoptotic cells represents a non¬
inflammatory mechanism for the removal of senescent neutrophils from
inflamed sites. The macrophage integrin av[33 and CD36 have been
proposed to act in concert to bind thrombospondin which forms a
molecular bridge between the surface of the macrophage and the
apoptotic neutrophil. This thesis has investigated the regulatory
mechanisms underlying this macrophage phagocytic system.
Phagocytosis of apoptotic neutrophils by monocyte-derived
macrophages was found to be modulated by short term pre-treatment of
macrophages with activators of protein kinase C and protein kinase A. In
contrast, FcR-mediated phagocytosis was unaffected by protein kinase
activation, suggesting specific modulation of this macrophage phagocytic
system. Examination of the molecules thought to be involved in this
phagocytic pathway revealed that thrombospondin production by
macrophages was undetectable after 30 minutes and no change in
thrombospondin binding or surface expression of av(33 and CD36
occurred following protein kinase activation. However, altered
distribution of the (33 integrin subunit did occur with a more localised
distribution observed following activation of protein kinase C.
Surprisingly, a number of monoclonal antibodies against av[33 did not
inhibit phagocytosis and av(33 was not found to colocalise with the
macrophage actin cytoskeleton or with ingested apoptotic neutrophils.
These results questions the involvement of av(33 in the phagocytosis of
apoptotic neutrophils.
Protein kinase A activation was seen to cause disruption of the
macrophage actin cytoskeleton. Other implicated inhibitors were
subsequently found to disrupt the macrophage actin framework. Since
cytoskeletal integrity is required for cell adhesion processes, the adhesion
state of the macrophage during phagocytosis of apoptotic neutrophils was
investigated. Adherence of macrophages to extracellular matrix proteins
was found to increase levels of phagocytosis compared to control
conditions. By contrast, very little phagocytosis was observed when the
assay was performed in suspension suggesting that the adhesion state of
the macrophage is an important factor in regulating phagocytosis of
apoptotic neutrophils.
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In summary, no evidence was obtained to support the direct
involvement of the av(33 integrin receptor in this phagocytic system.
Macrophage phagocytosis of apoptotic neutrophils can be modulated by
activation of protein kinases possibly by affecting the macrophage actin
cytoskeleton. Data presented in this thesis suggest that the adhesion state
of the macrophage is important in regulating phagocytosis of apoptotic
neutrophils. Thus the tissue micro-environment of the macrophage may
exert control over macrophage removal of apoptotic cells and hence the
process by which inflammation resolves.
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1.1. CELLULAR EVENTS IN INFLAMMATION.
In the aftermath of an insult to tissue, a stereotypic series of reactions is
initiated by the host in an effort to prevent further tissue damage, isolate
and destroy the injurious agent and instigate the repair process. This
cumulative homeostatic process is known as inflammation. The
manifestations of inflammation have been described as far back as
Roman times by Cornelius Celsus as rubor, tumor, calor and dolor
(redness, swelling, heat and pain) and the term inflammation is derived
from the Latin inflamare, meaning to burn.
The immediate and subsequent set of reactions that are induced are
known as the acute phase response (Baumann and Gauldie, 1994). A
number of factors can cause inflammation including bacteria and other
microbes, physical agents (burns, radiation, trauma), chemicals (toxins
and caustic substances), necrotic tissue and all types of immunologic
reactions. All of these insults are followed by a typical response. The
accumulation of leukocytes, primarily neutrophils and monocytes, is the
most important feature of the acute phase response. Chemokines are
released from the damaged site that control the migration of a variety of
cell types into the affected tissue. The recruitment and involvement of
leukocytes in the inflammatory response can be summarised as follows:
Margination: as slowing and stagnation of the blood flow occurs
leukocytes have increased contact with the endothelium.
Adhesion: involving specific interactions between complementary
adhesion molecules on the leukocyte and endothelium.
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Emigration: movement of leukocytes between the endothelial
cells, through the basement membrane into the extravascular space.
Chemotaxis: migration of cells in response to the chemotactic
agents released from the damaged site.
Phagocytosis: engulfment and disposal of injurious particle.
The cell types present in the inflammatory response vary with the age of
the lesion and the type of stimuli. However, in most types of acute
inflammation, neutrophils predominate in the first 6-24 hours, being
replaced by monocytes in 24-48 hours. Monocyte emigration is sustained
long after neutrophil emigration has ceased. This is accounted for by
chemotactic factors acting differentially on neutrophils and monocytes
during different phases of the inflammatory response.
The initial acute reaction to all types of injury lasts from a few minutes to
one or two days. The subsequent resolution of this reaction depends on
the nature and duration of the inflammatory stimulus, the type of tissue
injured and the degree of tissue damage caused by the agent. Acute
inflammation may terminate in one of four possible ways:
Resolution: complete restoration of the inflamed site to normal
structure and function.
Healing by scar: a result of substantial tissue damage. The lost
tissue may be either replaced by the formation of new tissue of the type
that was destroyed or the area may be filled by the in growth of newly
formed connective tissue (scar tissue).
Suppuration: a result of a persistent stimulus of the type that
evokes massive emigration of polymorphonuclear cells. Characterised by
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the formation of an inflammatory exudate (pus) containing large
numbers of degraded polymorphs and dead tissue cells.
Chronic inflammation: the inflammatory reaction persists for
weeks or months after the initial exposure to the damaging agent e.g.
pneumonia and arthritis.
Inflammation is considered a pathological response leading to tissue
damage and disease and much attention has been paid in the past to the
initiation and amplification of this process. However, little work has been
directed towards the mechanisms involved in the resolution of
inflammation which may provide significant insights as to why some
disease states persist rather than resolve.
1.2. MACROPHAGES.
1.2.1. Origin.
Macrophages are ubiquitously distributed throughout the body and are
involved in numerous homeostatic, immunologic and inflammatory
processes. Macrophages are derived from common precursors in the
adult bone marrow, circulate in the bloodstream as mature monocytes
which, under normal steady-state conditions, migrate into tissues and
body cavities where they differentiate into macrophages. The majority of
resident tissue macrophages are derived from monocytes. However, there
is evidence that a small percentage of macrophages derive from local
division of non-resident mononuclear phagocytes that have arrived in
tissues from the bone marrow before completion of cell division. Under
normal steady-state conditions, the macrophage population within
7
tissues remains constant and is regularly renewed by the influx of
monocytes (van Furth, 1992).
1.2.2. Macrophage phagocytic receptors.
The wide tissue distribution of macrophages and their phagocytic capacity
provide an immediate defence against foreign elements such as bacteria,
viruses, fungi and protozoa prior to leukocyte recruitment. Phagocytosis
involves the binding of a particle to the surface of the phagocyte and
subsequent engulfment of the bound particle. The attachment step is
mediated by specific macrophage receptors. Opsonisation of bacteria with
complement and/or immunoglobulin-G (IgG) permits macrophage
recognition and subsequent phagocytosis of invading micro-organisms.
The macrophage has three surface receptors that recognise the Fc domain
of IgG (Schriber et ah, 1992). FcRI (CD64: 72kD) is a high affinity receptor
for IgGl and IgG3, expressed mainly on macrophages and monocytes.
FcRII (CDw32: 40kD) has a lower affinity for IgG than FcRI and is
expressed on a variety of cell types including macrophages, platelets,
eosinophils and B cells. The third receptor, FcRIII (CD16: 51-73kD), is
found on neutrophils, natural killer cells and macrophages, but not
monocytes and has intermediate affinity for IgGl and IgG3. Ligation of Fc
receptors induces the release of reactive oxygen intermediates,
arachidonic acid metabolites and other mediators of inflammation. As
well as mediating avid binding and phagocytosis of particles coated with
immune complexes, Fc receptors are implicated in the removal of
senescent erythrocytes. Kay (1975) describes the in situ attachment of IgG
to senescent human erythrocytes thus making them susceptible to
macrophage phagocytosis.
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Many micro-organisms are capable of activating the complement cascade,
and C3b and C3bi, fragments of the third component, are major opsonins.
CR1 (CD35) is a glycoprotein, molecular weight 160-250kD, found on all
phagocytic leukocytes and recognises C3b. CR3 and CR4 bind C3bi and are
found on all phagocytic leukocytes, with regulated expression observed
upon monocyte-macrophage maturation. CR3 and CR4 are composed of
two non-covalently linked subunits (CDllb/CD18 and CDllc/CD18
respectively) and are members of the (32 family of integrins (Hynes, 1992).
Phagocytosis via CR1 and CR3 differs from that of FcR-mediated
phagocytosis in that receptor binding alone is not sufficient to induce
phagocytosis. Activation of the receptors, e.g. by substrate bound
fibronectin (Wright et al., 1983) or PMA (Wright et al., 1982), is necessary
to promote subsequent phagocytosis. Furthermore complement receptor-
mediated phagocytosis does not result in the release of inflammatory
mediators and may provide an alternative non-antagonistic pathway for
the clearance of opsonised particles during inflammation.
Glucose reacts non-enzymatically with amino acid groups of a wide range
of proteins throughout the body, including cell membrane proteins on
erythrocytes (Millar et al., 1980), to form advanced glycosylation
endproducts (AGE). Macrophages also express receptors for AGE and
these receptors have been shown mediate phagocytosis of AGE-modified
erythrocytes (Vlassara et al., 1987).
1.2.3. Macrophage functions.
Macrophages have diverse biological roles (Auger and Ross, 1992). The
wide tissue distribution of macrophages provides an immediate defence
against foreign elements such as bacteria, viruses, fungi and protozoa
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prior to leukocyte recruitment. Fc receptors and complement receptors
enable macrophages to recognise and phagocytose opsonised micro¬
organisms (section 1.2.2). Phagocytosis can also occur without
opsonisation if the micro-organism expresses surface molecules that are
directly recognised by the macrophage e.g. carbohydrate residues.
Furthermore, macrophages assist in cell-mediated immune responses
against pathogens, producing immunomodulatory cytokines and
regulating immunological responses. Phagocytosed antigen is processed
and presented to lymphocytes in conjunction with Class I or II molecules
of the major histocompatability complex (Unanue and Allen, 1987)
thereby stimulating antigen-specific T cells. Macrophages are a source of
many important secretory substances including cytokines and enzymes,
cytokine and enzyme inhibitors, growth factors, hormones, complement
components, coagulation factors and extracellular matrix proteins
(catalogued in Auger and Ross, 1992). Many of these secretory products
are induced by inflammatory or infectious stimuli and have roles in host
defence and the inflammatory response. Macrophages are also believed to
be involved in defence against tumours, secretory products inhibiting
tumour cell growth and leading to lysis of neoplastic cells (Adams and
Hamilton, 1992 and references therein).
1.2.4. Macrophages in inflammation.
Tissue macrophages are central to initiating the acute phase response.
Macrophages that have immigrated into sites of inflammation have a
large and diverse potential for further development. Upon activation
(Adams and Hamilton, 1984; Paulnock, 1992), resident macrophages
acquire increased capabilities for killing of micro-organisms and tumour
cells. Activated macrophages also display maximal secretion of
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inflammatory mediators such as tumour necrosis factor (TNF)-a,
prostaglandin E2 (PGE2), interlukin (IL) -1 and IL-6 (Keshav et al., 1990).
These cytokines act on stromal cells e.g. fibroblasts and endothelial cells,
causing a secondary release of cytokines including chemotactic factors for
neutrophils (e.g. IL-8) and monocytes (e.g. monocyte chemoattractant
protein). During an inflammatory reaction, there is increased recruitment
of peripheral blood monocytes to the perturbed site where they
differentiate into macrophages. The transition from monocyte to
macrophage occurs over approximately 48 hours and involves
considerable increase in size, the number of cytoplasmic organelles and
surface molecules involved in effector function thereby enhancing the
potential capabilities of the differentiated cell.
1.3. FATE OF THE NEUTROPHIL AT INFLAMED SITES.
Inflammation evolved as a regulated process which results in the
removal of invading pathogens and/or damaged cells and repair and
remodelling of host tissue. The neutrophil is the first cell recruited to
damaged areas and has evolved a variety of biological agents (listed in
Bainton, 1992) to aid bacterial killing. The ultimate fate of the large
numbers of recruited neutrophils during the resolution of inflammation
has received little attention until relatively recently (Haslett et al., 1989). It
had generally been assumed that neutrophils had a short tissue life and
that they inevitably underwent necrosis and disintegrated in situ before
their fragments were cleared by local phagocytes (Hurley, 1983). However,
in view of the capacity of many of the granule contents of neutrophils to
cause tissue damage (Weiss, 1989) and cleave tissue matrix proteins into
chemotactic fragments (Vitario et al., 1981) and evidence that neutrophil
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accumulation plays a role in other inflammatory events such as
generation of oedema (Wedmore and Williams, 1981) and influx of
monocytes (Doherty et al., 1988), necrotic neutrophil cell death would
tend to damage healthy tissues and exacerbate the inflammatory process.
Therefore, the clearance of the large number of neutrophils recruited to
damaged tissues may be a prerequisite for the resolution of acute
inflammation.
There is now evidence for an alternative fate of neutrophils whereby
macrophages phagocytose intact neutrophils that have undergone
apoptosis.
1.4. CELL DEATH: NECROSIS AND APOPTOSIS.
There are two main mechanisms of death in nucleated eukaryotic cells,
characterised by both morphologic and biochemical differences.
1.4.1. Necrosis.
Necrosis is a pathological response to gross tissue insult such as severe
hypoxia, ischemia or exposure to toxins and typically affects a number of
contiguous cells. Necrosis is characterised by disruption of membrane
integrity, including plasma, organelle and nuclear membranes, resulting
in lysis of the cell. It is thought that the critical event leading to the
development of necrosis is the loss of the properties of the membrane
that are involved in regulation of the cell volume; a fall in membrane
potential, loss of potassium from the cell and increased sodium entry.
The final critical event of necrosis is a gross change in membrane
permeability as demonstrated by the failure of the cell to exclude vital
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dyes. A fall in intracellular ATP levels may relate to the loss of
membrane function. The release of intracellular components as a result
of the rupture of the cells often induces an inflammatory response that
causes secondary tissue damage. Further aspects of necrosis have been
considered in greater detail by Wyllie et al. (1980).
1.4.2. Apoptosis.
In contrast to necrosis, apoptosis is characterised by retention of cell
membrane integrity and shrinkage of the cell. Its role in physiological and
pathological events has been extensively reviewed (Wyllie et al., 1980;
Raff, 1992; Cohen and Duke, 1992; Cohen, 1993; Krammer et al., 1994;
Ashwell et al., 1994). However, an overview of the main features will be
given here. This form of programmed cell death is morphologically
distinct from necrosis. The plasma membrane remains intact but becomes
ruffled and blebbed while the cytoplasm condenses and becomes
vacuolated. Apoptotic cells, in contrast to necrotic cells, do not show
evidence of increased membrane permeability and exclude vital dyes. The
most characteristic feature of apoptosis is the collapse of the nucleus
while all other organelles remain intact. The nuclear membrane usually
convolutes and the chromatin becomes condensed. Ultimately, the
nucleus breaks up into one or several condensed fragments. Finally, the
cell breaks up into membrane-bound apoptotic bodies which are
dispersed into the intercellular tissue space and are either extruded into
an adjacent lumen or, more commonly, phagocytosed by other cells.
Apoptosis is a gene directed process. Evidence for this has come from
work carried out on the nematode C. elegans in which, at specific stages
of development, a number of cells die by apoptosis. The activity of two
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genes, ced-3 and ced-4, is necessary for apoptosis to occur (Ellis and
Horvitz, 1986). In contrast, activation of the gene ced-9 suppresses
apoptotic cell death (Hengartner et al., 1992). A homologue of ced-9 is bcl-
2 which has been shown to spur apoptosis in mammalian cells (Vaux et
al., 1988: Hengartner and Horvitz, 1994). The effect of Bcl-2 may be
regulated by a related gene product, Bax (Oltvai et al., 1993). The
mammalian homologue of ced-3 and ced-4 that induces apoptosis is IL-ip
converting enzyme (ICE: Lazebnik et al., 1994). In addition, c-myc has also
been shown to induce apoptosis in mammalian cells (Evans et al., 1992:
Shi et al., 1992). Like bcl-2, c-myc is regulated by dimerisation with max
(Blackwood and Eisenman, 1991). The nuclear collapse in apoptosis is
associated with degradation of cellular DNA into single and multiple
nucleosomes that results in the characteristic "ladder" pattern
electrophoresis. This degradation of DNA appears to be a result of an
enzymatic process, although the properties of the endogenous
endonuclease remain to be determined.
Apoptosis is a physiological mode of cell death implicated in the steady-
state kinetics of healthy tissues. Apoptosis characteristically affects single
cells within tissues but during events such as embryological remodelling,
large fields of cells undergo apoptosis. Even under these circumstances,
apoptotic cell death does not induce an inflammatory response due to
preservation of membrane integrity and rapid phagocytosis of apoptotic
bodies.
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1.4.3. Apoptosis in neutrophils.
Neutrophils constitutively undergo apoptosis during ageing in vitro
(Savill et al.r 1989a) however, the rate of apoptosis can be modulated by
inflammatory mediators such as GM-CSF, C5a and LPS (Brach et al., 1992:
Lee et al., 1993). Whyte et al. (1993a) also report inhibition of neutrophil
apoptosis upon elevation of intracellular free calcium, an event that has
been shown to trigger apoptosis in other cells (McConkey et al., 1989a:
McConkey et al., 1989b: Allbritton et al., 1988). In addition to the
characteristic morphological and nuclear changes associated with
apoptosis (Wyllie et al., 1980), Dransfield et al. (1994) describe altered CD16
expression on the surface of apoptotic neutrophils. During apoptosis,
neutrophil membrane integrity is preserved and granule contents are
retained within the cell (Savill et al., 1989a) and a number of neutrophil
functions such as chemotaxis, phagocytosis and granule release (Whyte et
al., 1993b) are down regulated. Phagocytosis of neutrophils by
macrophages is also determined by apoptosis (Savill et al., 1989a).
1.5. MACROPHAGE RECOGNITION OF APOPTOTIC CELLS.
1.5.1. Overview.
The rapid phagocytosis of apoptotic cells may prevent potential tissue
damage as a result of lysis of these cells in situ. A number of apoptotic cell
types have been identified as being recognised and phagocytosed by
macrophages. Recognition of apoptotic cells is thought to involve
multiple receptor-ligand interactions and current findings are
summarised in Table 1.1. It is not known if recognition of apoptotic
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(1985) also mediates phagocytosis of the apoptotic cell as this was a
rosetting assay performed at 4°C. However, a role for a lectin in the
uptake of apoptotic hepatocytes in rats has been indicated (Dini et al.,
1992). Fadok et al. (1992b) have also suggested that the mechanism by
which apoptotic cells are recognised and phagocytosed by macrophages
may be determined by the subpopulation of macrophages being
examined. In a study of four different macrophage populations, murine
peritoneal macrophages were found to bind apoptotic cells via
phosphatidylserine while murine bone marrow macrophages use both
the vitronectin receptor, av(33, (like human monocyte-derived
macrophages) and phosphatidylserine receptor-dependent pathways
(Fadok et al., 1992b). Recently, another macrophage surface antigen has
been identified as a mediator of apoptotic cell recognition (Flora and
Gregory, 1994). Recognition of apoptotic neutrophils and lymphocytes
was inhibited by the mAb 61D3, a widely used marker of
monocyte/macrophage lineage cells. Furthermore, this recognition
pathway is distinguishable from the av(33 mechanism involved in the
recognition of apoptotic neutrophils. Thus, the mechanisms underlying
rapid clearance of apoptotic cells may involve multiple phagocytic
receptors.
1.5.2. Macrophage phagocytosis of apoptotic neutrophils.
Phagocytosis of neutrophils by macrophages has been described as far back
as the turn of the century by Metchnikoff, providing evidence of an
alternative neutrophil disposal route. A proportion of human monocyte-
derived macrophages (mo) constitutively recognise and phagocytose aged
apoptotic, but not freshly isolated, neutrophils (Newman et al., 1982;
Savill et al., 1989a) indicating that the apoptotic cell provides a phagocytic
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signal to the mo. In contrast to macrophage phagocytosis of particles
opsonised with immunoglobulin, phagocytosis of apoptotic neutrophils
does not evoke the release of pro-inflammatory macrophage mediators
such as thromboxane B2 or N-acetyl-fJ-D-glucosamine (Meagher et al.,
1992). Such a mechanism for neutrophil clearance would tend therefore
to limit tissue injury and promote resolution of inflammation and there
is now clear histological evidence for the involvement of this process in
acute inflammation (Savill et al., 1989a; Jones et al., 1993).
Two distinct recognition mechanisms have been described for human
monocyte-derived macrophage phagocytosis of apoptotic neutrophils
(Savill et al., 1992; Flora and Gregory, 1994). Work presented in this thesis
is based on the model for human macrophage recognition of apoptotic
neutrophils proposed by Savill and colleagues in which three different
molecules are thought to be involved: (1) the mo integrin av(33
(CD51/CD61) (Savill et al., 1990), (2) mo CD36 and (3) the extracellular
matrix molecule thrombospondin (Savill et al., 1992). Savill and co¬
workers have proposed a model in which avP3 and CD36 on the mo
surface act in concert to bind thrombospondin, thus forming a molecular
bridge between the mo and an as yet unknown moiety on the apoptotic
neutrophil surface (Fig. 1.1).
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Figure 1.1. Proposed mechanism by which macrophages recognise
apoptotic neutrophils.
M0 av(33 and CD36 act in concert to bind thrombospondin which acts as a
molecular bridge between the mo and an unknown moiety (?) on the
surface of the apoptotic cell (Savill et al, 1992). Reproduced with
permission from Dr. I. Dransfield.
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1.6. MOLECULAR MECHANISM OF MACROPHAGE PHAGOCYTOSIS
OF APOPTOTIC NEUTROPHILS.
1.6.1. The avf33 vitronectin receptor.
The vitronectin receptor, av(33, is a member of the integrin family of
adhesion molecules which are the major receptors mediating adhesion of
cells to the extracellular matrix (ECM) and some important cell-cell
adhesion events. Integrin expression is universal, at least one member of
the family has been found on every cell/tissue studied. All integrins are
heterodimers of a 120-180kD a-subunits noncovalently linked to smaller
(3-subunits (90-1 lOkD). At least sixteen a-subunits and eight p-subunits
have been identified. Many a-subunits associate with only one p-subunit,
but several can associate with more than one p-subunit and, to date,
twenty distinct integrin receptors are recognised (Hynes, 1992). Both
subunits are transmembrane glycoproteins with short carboxyl terminal
cytoplasmic domains, a single hydrophobic transmembrane segment and
large globular amino terminal extracellular domains that associate to
form the heterodimer. The subunits are products of different genes and
have been highly conserved in evolution, the P-subunits show 37-45%
homology while the a-subunits are 25-30% homologous.
Integrins are a phylogenetically ancient family of molecules. The term
"integrin" was first coined as these receptors provide a transmembrane
link between the outside of the cell and the cytoskeleton and were found
to be homologous to the chicken fibroblast fibronectin receptor (the
chicken integrin) (Tamkun et al.r 1986). The extracellular domains of
integrins interact with a wide variety of ligands including ECM
glycoproteins, complement components and cell surface glycoproteins. It
is likely that the ligand binding site is contributed to by both subunits.
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Some integrins bind different ligands while others can bind only one.
Furthermore, several different integrins can bind to the same ligand but
the same sequence is not always recognised. The binding of integrin and
ligand requires divalent cations and is of low affinity (10"6M). Putative
divalent cation binding sites may be present on both subunits. Integrin p-
subunit cytoplasmic domains have been shown to indirectly associate
with the actin skeleton via cytoskeletal proteins such as talin (Horwitz e t
al., 1986) and a-actinin (Otey et al., 1990). There is less evidence for
interaction of the a-subunit cytoplasmic tail with intracellular proteins
although Leung-Hagesteijn and co-workers (1994) have demonstrated
that calreticulin, an intracellular calcium-binding protein binds to an
integrin a-subunit and can affect cell attachment to ECM substrates.
As well as providing a physical link between the cell and the ECM, it is
clear that integrins are capable of transducing signals that affect a range of
cellular events. The avidity of integrin complexes for their ligand can be
modulated by inside-out signals from other receptors or accessory
molecules (Ginsberg et al., 1992) while outside-in signals from integrin-
ECM contacts promotes phosphorylation of intracellular components
despite the cytoplasmic domains having no intrinsic kinase activity
(Damsky and Werb, 1992). Cellular responses to extracellular information
is tightly regulated. Integrin-related signals are transduced in co-operation
with other classes of adhesion receptors and/or growth factor receptors to
ensure cells respond in the appropriate environmental context.
Dysregulation of such integrated responses appear to be fundamental to
the aetiology of disease.
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The av(33 receptor is a member of the "cytoadhesin" subfamily of
integrins and is expressed on a number of cell types. In terms of ligand
binding, it is a highly promiscuous receptor, binding vitronectin,
fibronectin, thrombospondin and fibrinogen via the RGD recognition
sequence present in these molecules. av(33 is involved in a variety of
biological activities including cell spreading and migration, tumour
metastasis, bone resorption and cell signalling (see Felding-Habermann
and Cheresh, 1993 and references therein).
1.6.2. Thrombospondin and the glycoprotein CD36.
The thrombospondin family comprises of five homologous proteins,
thrombospondin 1-4 and cartilage oligomeric matrix protein, all of which
are products of separate genes (Adams and Lawler, 1993). Initially isolated
from a-granules of thrombin-stimulated platelets, thrombospondin-1 is
secreted by a number of cell types including macrophages (Jaffe et al., 1985;
Savill et al., 1992) and inflammatory neutrophils (Kries et al., 1989).
Thrombospondin has been implicated in a number of cellular processes
including angiogenesis, inflammation, cell development and
homeostasis. Of most relevance for this project however, is its
involvement in cell-cell adhesion. Thrombospondin has been described
as a molecular bridge for a number of cell-cell interactions including
platelet-platelet aggregation (Silverstein et al., 1986), platelet-monocyte
and platelet-macrophage adhesion (Silverstein and Nachman, 1987) as
well as between macrophages and apoptotic neutrophils in the process of
phagocytosis of the apoptotic cell (Savill et al., 1992). Also of relevance is
the presence of thrombospondin in the extracellular matrix during early
stages of wound repair (Raugi et al., 1987) at a time when neutrophils
would be removed from the tissue. Other functions of thrombospondin
22
and its involvement in physiology and pathophysiology has been
reviewed recently (Lahav, 1993).
Thrombospondin comprises three identical subunits made up of several
discrete structural domains (Fig. 1.2). The heparin binding domain is a
small globular domain at the amino terminus of the peptide that binds to
soluble heparin, cell-surface heparin sulphate proteoglycans and to
sulfatides. Adjacent to the heparin binding domain are two cysteine
residues one of which is involved in the formation of the
thrombospondin trimer. The central core segment contains three types of
repeating sequences (type I, II and III repeats) accounting for about half of
the thrombospondin subunit. The second and third of the type I repeats
have been shown to contain a major cell binding site centred around the
Cys-Ser-Val-Thr-Cys-Gly sequence. The type II repeats contain sequences
that may bind to soluble macromolecules, while a third cell binding
sequence, Arg-Gly-Asp (RGD), is found in the last of the type III repeats.
The carboxy-terminal domain is capable of binding a number of cell types
by novel sequences that bear no homology to other adhesive proteins.
Therefore, each subunit has at least four direct cell binding sites
(reviewed in detail by Frazier, 1991) as well as sequences for the
interaction of thrombospondin with other macromolecules.
Five distinct receptors have been identified for thrombospondin
(reviewed in Frazier, 1991) including the integrin av(33 which recognises
the Agr-Gly-Asp sequence in the type III repeats of thrombospondin
(Lawler and Hynes, 1989) and the glycoprotein CD36 that binds to the type
I repeats containing the Cys-Ser-Val-Thr-Cys-Gly motif (Li et al., 1994).









Figure 1.2. Schematic representation of a subunit of thrombospondin.
Location of the type I, II and III repeats are shown as well as the positions
of the heparin binding domain, the RGD binding sequence and the cell
binding domain (Adapted from Frazier, 1991).
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glycoprotein of molecular mass 88kD. It is expressed on a number of cell
types including platelets, endothelial cells, monocytes and a variety of
tumour cell lines (Asch et al., 1987) as well as fibroblasts (Stomski et al.,
1992) and macrophages (Silverstein et al., 1989) and has been identified as
the receptor for thrombospondin in these cells. It has been shown to
mediate platelet-monocyte and platelet-macrophage thrombospondin-
dependent cell adhesion (Silverstein et al., 1989) and is involved in the
adhesion of malaria parasitized erythrocytes to microvasacular
endothelium (Johnson et al., 1993).
1.7. MODULATION OF MACROPHAGE PHAGOCYTOSIS OF
APOPTOTIC NEUTROPHILS.
While much is understood about the mechanism of mo recognition of
apoptotic neutrophils, little is known about the modulation of this
system which would have important implications for regulating the
resolution process of inflammation. There are several potential control
mechanisms for the recognition and phagocytic pathways by which
apoptotic cells are removed.
Necrotic neutrophils are also found at inflamed sites, thus the balance
between apoptosis and necrosis could represent a pivotal point in the
control of inflammation. Inflammatory mediators and growth factors
prolong the lifespan of myeloid cells by inhibition of the rate of apoptosis
in these cell populations (Brach et al., 1992; Lee et al., 1993). It has been
shown that for neutrophil granulocytes, inhibition of apoptosis confers
longevity of a range of cellular functions including phagocytic and
secretory responses (Lee et al., 1993). The rate at which neutrophils
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undergo apoptosis at inflamed sites would serve a dual purpose of
regulating the potential for neutrophil-mediated damage at these sites
and the numbers of neutrophils that are available for recognition by mo.
Another level of control is regulation of the phagocytic potential of the
macrophage. The novel receptors mediating macrophage recognition of
apoptotic cells are critical determinants of the lack of macrophage
secretory response (Meagher et al., 1992). Alteration of mo phenotype may
result in expression of the receptors that are involved in the phagocytic
process. During the process of human monocyte differentiation to
macrophages in vitro, expression of ocvP3 is induced (Andreesen et al.,
1990; Krissansen et al., 1990) concomitantly with acquisition of the
capacity to phagocytose apoptotic cells (Savill et al., 1990). For murine
macrophages, different phenotypes may be induced by local micro-
environmental stimuli. In contrast to macrophages isolated from the
peritoneal cavity that employ phosphatidylserine receptors, bone
marrow-derived macrophages utilise an avP3 integrin-based recognition
mechanism (Fadok et al., 1992b). Thus, modulation of receptor expression
during monocyte differentiation may determine the phagocytic ability of
macrophage populations at different anatomic sites.
In addition to alteration of cell phenotype (rate of neutrophil apoptosis
and monocyte-macrophage differentiation) which may occur over a
period of hours, rapid control may be achieved by regulation of the
function of receptors already present upon the mo surface. Receptor
function may be rapidly turned on and off in response to environmental
signals. Integrins are used by cells to sense and respond to micro-
environmental stimuli and functional activity can be regulated from
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within the cell, either as a result of altered cell surface distribution (Tang
et ah, 1993), or conformational changes that affect ligand binding affinity
(Ginsberg et ah, 1990; Frelinger III et ah, 1991). Cells are therefore able to
dynamically modulate their repertoire of possible adhesive interactions
mediated by these receptors in response to extracellular signals (Damsky
and Werb, 1992; Ginsberg et ah, 1992). Thus the integrin av(13 represents a
potential regulatory element in macrophage recognition of apoptotic
neutrophils.
1.8. AIMS.
The aim of this thesis is to investigate mechanisms involved in
modulating macrophage recognition of apoptotic neutrophils. Initial
experiments sought to investigate whether regulation of the functional
properties of the molecules implicated in the recognition process, notably
the macrophage av|33 receptor, served to impart control over this
phagocytic system, pi, p2 and p3 integrin function has been shown to be
modulated by activation of intracellular protein kinases (Dustin and
Springer, 1989; Shimizu et ah, 1990). avp3-mediated adhesion is induced
in a number of pi-negative B cell lines following activation of protein
kinase C (Stupack et ah, 1992). Therefore, the effect of short term
pretreatment of monocyte-derived macrophages with activators of
protein kinase on phagocytosis of apoptotic neutrophils was assessed. As
integrins provide a transmembrane link between the interior of the cell
and the extracellular environment, the relationship of macrophage avp3
receptor and the actin cytoskeleton was also examined. Subsequently, the
importance of the adhesion state of the macrophage during phagocytosis
of apoptotic neutrophils was investigated.
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CHAPTER 2. MATERIALS AND METHODS.
2.1. MATERIALS
2.1.1. Reagents.
All chemicals were obtained from Sigma Chemical Co., Poole, U.K. unless
otherwise stated. Iscove's Dulbeco's modified Eagles medium (Iscove's
DMEM), Hanks balanced salt solutions (HBSS) and culture supplements
(Penicillin/Streptomycin) were from Gibco Laboratories, Paisley, Scotland
and sterile tissue culture ware from Falcon Plastics, Becton Dickinson,
Oxford, U.K. Phorbol 12,13-dibutyrate (PdBu) was purchased from
Calbiochem, Nottingham, U.K. and a stock solution prepared in
dimethylsulphoxide (DMSO) at lmg/ml. 20mM stock solution of
dibutyryladenosine 3'.5'-cyclic monophosphate (dbcAMP; Sigma) was
prepared in Iscove's DMEM. Prostaglandin E2 (PGE2; Sigma) was prepared
in ethanol at a concentration of 3mM while 50mM isobutyl methyl xanthine
(IBMX; Sigma) was prepared in DMSO and isoquinolinylsulfonyl
methylpiperazine (H-7; Sigma) was prepared in DMSO at a concentration of
0.23M. All stock solutions were stored at -20°C and diluted as required in
Iscove's DMEM. Stock solutions of the ECM glycoproteins fibronectin (Fn;
Sigma), vitronectin (Vn; Calbiochem) and collagen type I and type VI (Col I
and Col VI; Gibco) were prepared in PBS at lmg/ml, stored at -80°C and
used in experiments at 10|ig/ml PBS. Thrombospondin was purified by Dr.
Ian Dransfield (Rayne Laboratory, University of Edinburgh, Scotland) from
thrombin-activated platelets as described (Lawler et al., 1985).
2.1.2. Antibodies.
Antibodies used in this study were rabbit immunoglobulins (Ig) to human
erythrocyte membrane antigens, fluorescein isothiocyanate (FITC)-
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conjugated F(ab')2 fragment of rabbit Ig to mouse Ig, peroxidase-conjugated
rabbit Ig to mouse Ig, biotinylated rabbit Ig to mouse Ig and
ABComplex/AP, all from DAKO, Denmark. Monoclonal antibodies (mAb)
are of IgGi isotype unless otherwise stated. 23C6 (CD51/CD61 [av(33]
complex) and 13C2 (CD51 lav]) were provided by Dr. Mike Horton, ICRF,
London (Davis et al., 1989). Purified PM6/13 (CD61 [(33]; Shaw, 1994) was
generously supplied by Dr. Mike Wilkinson, Royal College of Surgeons,
London while SM0 (CD36; IgM; Hogg et al., 1984) and mAb29 (CD15; IgM)
were provided by Dr. Nancy Hogg, ICRF, London. FA6-152 (CD36) was
selected from antibody panels obtained from the 5th International Workshop
on leukocyte differentiation antigens (Shaw, 1994). mAb specific for
thrombospondin, MA-I (type III repeats; Lawler et al., 1985) and MA-IV
(heparin binding domain) were the gift of Dr. Jack Lawler, Harvard Medical
School, Boston. The hybridoma MOPC-21C (non-binding IgGi control mAb)
was purchased from the European Animal Cell Culture collection, Porton
Down, U.K. LIBS1 (activated CD61; Frelinger III et al., 1990) was generously
provided by Dr. Mark Ginsberg, Research Institute of Scripps Clinic, La Jolla,
U.S.A. Mouse monoclonal antibody to human talin was purchased from
Serotec Ltd, Oxford, U.K. TS2/16 (a CD29 [(31] stimulatory mAb; Arroyo et
al., 1992), mAbl3 (a CD29 [(31] inhibitory mAb; Berdichevsky et al., 1992) and
BIIG2 (CD49e [a5]; Werb et al., 1989) were donated by Dr. Don Salter,
Department of Pathology, University of Edinburgh, Scotland. SAM-1 (CD49e
[a5]) was supplied by Carl Figdor, University Hospital Nijmegan, Holland.
mAb Bob 75 (CD15; IgM) was supplied by Dr. Jim Ross, Lister Laboratories,
University of Edinburgh, Scotland and the UCHM1 clone (CD14; IgG2a;




2.2.1. Cell separation using a Percoll density gradient centrifugation
technique.
Mononuclear cells (MNC) and polymorphonuclear granulocytes (PMN)
were isolated from peripheral blood using a modification of the method
previously described by Savill et ah, 1989a. 40ml of freshly drawn citrated
blood was added to 50ml Falcon tubes (Falcon Plastics) containing 4ml of
3.8% sodium citrate and centrifuged in an MSE Mistral 3000 centrifuge
(Sanyo Gallenkamp, Loughborough, U.K.) at 300g for 20 minutes.
Autologous serum was prepared at 37°C in glass tubes by recalcification of
10ml of the platelet-rich plasma layer using 220pl of 0.32% calcium chloride.
Platelet-poor plasma (PPP) was also prepared by centrifugation of the
platelet-rich plasma layer at 2500g for 20 minutes. Leukocytes were enriched
from the cell pellet by sedimentation of erythrocytes for 30 minutes with 6%
dextran T500 (1ml dextran/4ml blood cell pellet). The cells, spun out of the
leukocyte-rich layer, were then resuspended in 3ml of 55% isotonic Percoll
(9:1 vol./vol. PercollrlOx PBS) in HBSS without Ca2+/Mg2+. The cell fraction
was then overlaid in 15ml Falcon tubes onto 3ml of 70% isotonic Percoll,
previously overlaid on 3ml of 81 % isotonic Percoll, and spun at 700g for 20
min (Dooley et ah, 1982). MNC were aspirated from the 55%/70% interface
and PMN from the 70%/81% interface and washed initially in PPP, then
HBSS without Ca2+/Mg2+ and finally HBSS with Ca2+/Mg2+ (lOOOrpm, 6
minutes). MNC were, on average, >95% pure and PMN >98% pure as
assessed by cytospin preparations.
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2.2.2. Cell separation by counterflow centrifugation elutriation.
A J-21M/E Beckman centrifuge (Beckman Instruments (U.K.) Ltd, High
Wycombe, U.K.) fitted with a JE-6 elutriator rotor, was used in conjunction
with a Masterflex peristaltic pump (supplied by Beckman) to regulate the
flow rate of the medium through the system (Fig. 2.1). After purging with
alcohol and distilled water, the circuit was thoroughly flushed through with
HBSS with Ca2+/Mg2+ containing 0.2% PPP (elutriation medium) taking
care to remove any air trapped within the tubing. Cells, pelleted from the
leukocyte-rich layer (2.2.1), were pooled in a 10ml syringe and loaded into
the sample chamber of the elutriator, the 3-way taps set to bypass the sample
chamber. The cells were then loaded into the separation chamber by
redirecting the elutriation medium through the sample chamber. Separation
of the leukocytes was achieved by increasing the flow rate of the elutriation
medium through the system. Cells were collected in 50ml fractions and the
purity of each fraction assessed using an EPICS Profile II flow cytometer
(Coulter Electronics, Luton, U.K.). Monocytes were pooled and cultured as




Monocytes were cultured either adherent to tissue culture plastic or in
suspension in Teflon foils.
i) For adherent cell culture, MNC were resuspended at 4xl06/ml in Iscove's
DMEM, allowed to adhere to 24 well tissue culture plates for one hour at
37°C, non-adherent cells removed and the monocytes washed twice in HBSS











Figure2.1.D agramofelutri tionsyste . B.V.-bypassvalve:I.s mpleinjectionl :SC-separationch mber. ReproducedwithpermissionfroDr.ACon liffe,aynLab at ryUniversityEdinburgh.
DMEM containing 10% autologous serum, with a change of medium on day
3 as previously described (Savill et ah, 1989a).
ii) For suspension culture, monocytes were separated from non-adherent
lymphocytes by adherence of MNC to plasma-coated tissue culture dishes
(Ackerman and Douglas, 1978). 140mm tissue culture dishes (Falcon Plastics)
were incubated for 1 hour at 37°C with 3ml PPP, diluted 1:10 with PBS, per
plate. The plates were then washed twice with PBS and 1.4xl07 MNC, in 7ml
Iscove's DMEM containing 10% autologous serum, were added to each dish
and incubated for 1 hour at 37°C. Non-adherent cells were removed by two
washes in HBSS with Ca2+/Mg2+. Adherent cells were then detached by
incubation with warm (37°C) PBS containing 5mM EDTA (BDH, Glasgow,
U.K.) and 1% autologous serum for 10 minutes at 37°C. Monocytes obtained
by this method (>90% pure by cytospin preparation; Fig 2.2) or by elutriation
were then washed and resuspended at lxl06/ml Iscove's DMEM containing
10% autologous serum and cultured for six days at 37°C in a 5% CO2
atmosphere in sterile hydrophobic Teflon (ChemFab, Handforth, Cheshire,
U.K.) foils. The foils were prepared by sealing the corners of Teflon squares
with an HM3000 Impulse heat sealer (Hume Martin Ltd, London, U.K.) to
form trays of approximately 1cm deep.
2.3.2. Neutrophils.
Neutrophils were cultured at 4xl06/ml in Iscove's DMEM containing 10%
autologous serum in 5ml hydrophobic Teflon bags or tissue culture flasks at
37°C in a 5% CO2 atmosphere for 18-24 hours. During this time a proportion
of the cells underwent spontaneous apoptosis (Savill et ah, 1989a), as
determined by morphological appearance.
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Figure 2.2. Isolation of monocytes from mononuclear cells.
Top panel: Photomicrograph of mononuclear cells isolated from peripheral
blood using a discontinuous Percoll density gradient. Magnification x400.
Lower panel: Photomicrograph of monocytes purified from mononuclear
















2.4. ASSESSMENT OF APOPTOSIS.
After 18-24 hours in culture, apoptosis of the neutrophils was quantified
microscopically by morphological appearance, nuclear condensation and
cytoplasmic vacuolation (Wyllie et ah, 1980; Fig. 2.3). That the cells were
"viable" rather than necrotic was determined by trypan blue exclusion. For
assessment of macrophage phagocytosis of apoptotic cells, neutrophils were
>50% apoptotic and <2% necrotic (i.e. >98% excluding trypan blue).
2.5. STANDARD PHAGOCYTOSIS ASSAY FOR APOPTOTIC
NEUTROPHILS.
2.5.1. Macrophages cultured in tissue culture plates.
Phagocytosis of apoptotic neutrophils was assayed by minor modifications
of previously described methods (Newman et al., 1982). Monocyte-derived
macrophages (mo), cultured for six days in 24 well tissue culture plates, were
washed once with Iscove's DMEM and 4x106 apoptotic neutrophils,
resuspended in Iscove's DMEM, were added to each well. After 30 minutes
incubation at 37°C, wells were washed 3-5 times with ice cold PBS, fixed in
PBS containing 2.5% glutaraldehyde for 10 minutes and stained for
myleoperoxidase (MPO) at 37°C for 30 minutes using hydrogen peroxide
and 0.1 pM dimethoxybenzidine (o-diansidine) as substrate. Apoptotic
neutrophils are 100% MPO-positive while six day mo are 100% MPO-
negative (Fig. 2.4). The percentage of mo phagocytosing MPO-positive
apoptotic neutrophils was quantified microscopically by examination of 4-5
randomly selected fields (a minimum of 500 cells). Experiments were carried
out in duplicate or triplicate wells.
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Figure 2.3. Morphological appearance of apoptotic neutrophils.
Neutrophils, aged for 18-24 hours in culture, which displayed nuclear




Figure 2.4. Myleoperoxidase staining of apoptotic neutrophils
phagocytosed by macrophages.
Neutrophils, phagocytosed by mo, are readily identifiable by the
orange/brown staining of MPO (arrows). Magnification xlOOO.
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2.5.2. Macrophages cultured in Teflon foils.
Mo, recovered from Teflon foils by aspiration, were resuspended at
lxl06/ml Iscove's DMEM and either 105/well added to 96 well tissue culture
plates or multispot microscope slides (C.A. Hendley (Essex) Ltd, Essex, UK.)
or 1.5x105/well added to 8 well chamber slides (Gibco) and allowed to
adhere by incubation for lh at 37°C. After rinsing with Iscove's DMEM,
lxl06/well of apoptotic neutrophils were added to the 96 well plates or
multispot slides for 30 minutes at 37°C (1.5xl06/well to the chamber slides).
Wells were then washed, fixed with glutaraldehyde and stained for MPO as
described in 2.5.1.
2.6. PHAGOCYTIC ASSAY FOR IgG OPSONISED ERYTHROCYTES.
Erythrocytes were obtained from the red blood cell pellet following dextran
sedimentation of the whole blood, washed in HBSS without Ca2+/Mg2+,
resuspended at 25xl06/ml HBSS without Ca2+/Mg2+ and incubated at 4°C
with rabbit IgG to human erythrocyte membrane (1:100) for 30 minutes.
Opsonised erythrocytes were then washed, resuspended at 4xl06/ml HBSS
with Ca2+/Mg2+ and incubated with mo on 24 well tissue culture plates as
described for apoptotic neutrophils (2.5.1). After 30 minutes, the wells were
washed once with PBS and non-phagocytosed erythrocytes were lysed with
one drop of water per well for approximately 30 seconds after which time
PBS was added to the wells and two further PBS washes carried out. The
cells were then fixed with glutaraldehyde and stained for MPO as described
in 2.5.1., erythrocytes staining MPO-positive.
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2.7. MODIFICATIONS OF THE STANDARD PHAGOCYTOSIS ASSAY.
2.7.1. Pretreatment of macrophages with activators of protein kinase C and
protein kinase A.
Mo were washed once with Iscove's DMEM and incubated for 15 minutes at
37°C with either 50nM PdBu (protein kinase C [PKC] activator) using
DMSO, diluted by the same amount as a control, 2mM dbcAMP (protein
kinase A [PKA] activator) or 3|xM, 1.5pM or 0.3pM PGE2 plus 0.5mM IBMX
(PKA activation) or 6pM H-7 (PKC inhibitor). Iscove's DMEM was the
control for the dbcAMP and PGE2 treatments. The treated cells were then
washed once with Iscove's DMEM prior to assessment of phagocytosis of
apoptotic neutrophils or opsonised erythrocytes as previously described
(2.5.1 and 2.6). There was no significant difference in the amount of
phagocytosis between the two control conditions and for subsequent
experiments using PdBu, Iscove's DMEM was used as the control medium.
2.7.2. Pretreatment of macrophages with antibody.
i) Mo, cultured in suspension and adhered to 96 well tissue culture plates or
multispot microscope slides (2.5.2), were washed once with Iscove's DMEM
and incubated for 15-20 minutes at room temperature with 50pl of relevant
mAb optimally diluted in Iscove's DMEM. Apoptotic neutrophils were
added to each well with the mAb still present and the assay carried out as
described in 2.5.2.
ii) Mo, cultured in suspension, were resuspended in Iscove's DMEM and
1.5xl06 cells incubated at 4°C for 30 minutes with mAb in 96 flexiwell plates
(Becton and Dickinson, Oxford, U.K.). Cells were then adhered to wells of
chamber slides in the presence of the mAb for 1 hour after which time the
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cells were washed and the phagocytosis assay carried out as described
(2.5.2).
2.7.3. Plating of macrophages on different matrix substrates.
8 well chamber slides were coated overnight at 4°C with lOpg/ml of Fn, Vn,
Col I and Col VI. Mo, cultured in Teflon foils, were spun out of the culture
medium with lOmM EDTA. The wells were washed twice with PBS and
1.5xl06 mo, resuspended in Iscove's DMEM, were added to each well and
adhered for 1 hour at 37°C and the phagocytic assay carried out as
previously described (2.5.2).
2.8. MEASUREMENT OF cAMP LEVELS IN MACROPHAGES TREATED
WITH PGE2.
2.8.1. Preparation of cell samples.
Mo were cultured over six days from MNC adherent to 6 well tissue culture
plates as described in 2.3.1. The cells were washed once with Iscove's DMEM
and incubated with Iscove's DMEM or Iscove's DMEM containing 0.5mM
IBMX and 3(iM PGE2 for 0.5, 2, 5, 10, 15 or 45 minutes. The reactions were
terminated by rapid aspiration of the medium followed by the addition of
600|il ice cold 0.5M trichloroacetic acid. The cells were left to extract on ice
for 20 minutes then scraped off and transferred to eppendorf tubes. The
samples were then vortexed and centrifuged (lOOOOg, 5 minutes) and 500|il
of the supernatant added to 125(0.1 of lOmM EDTA (pH 7.0) and 500(il of
freshly prepared 1,1,2-trichlorotrifluroethane (BDH)/tri-n-octylamine (50:50,
v/v; Downes et ah, 1986). After further vigorous mixing the samples were
centrifuged (lOOOOg, 2 minutes) and 500|il of the aqueous layer removed and
neutralised with 100(il 6M sodium hydrogencarbonate. Three 50pl aliquots
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from each sample were then used in the cyclic AMP (cAMP) assay (section
2.8.2).
2.8.2. cAMP radioreceptor assay.
Assays were performed in triplicate at 4°C in a final volume of 300(1.1. Each
tube contained 50(0.1 buffer (50mM Tris-HCl, 4M EDTA, pH 7.5), 50fil sample
or standard containing known amounts of cAMP (doubling dilutions from
0.125-16pmol with 250pmol cAMP used to define non-specific binding) and
lOOpl [3H]-cAMP (88000 dpm; DuPont (U.K.) Ltd, Stevenage, U.K.). The
reaction was initiated by addition of 150(il cAMP binding protein (final
concentration, 0.85(ig protein/ml; prepared by Dr. Edwin Chilvers, Rayne
Laboratory, University of Edinburgh, Scotland, as described in Brown et ah,
1971) and incubated overnight at 4°C. The reaction was terminated by the
addition of 250(0.1 0.5% activated charcoal (BDH). After 3 minutes, the
samples were centrifuged (lOOOOg, 4 minutes) and 200|il of the supernatant
transferred to 5ml scintillation vials (Canberra Packard, Pangbourne, U.K.).
5ml of Flo-Scint™ IV scintillation fluid (Canberra Packard) was added to
each vial and the samples analysed on a liquid scintillation counter
(Canberra Packard). Figure 2.5 shows a typical standard curve representative
of four experiments.
2.9. FLOW CYTOMETRY.
Mo, cultured in suspension, were resuspended at 1x10^/ml Iscove's DMEM.
105 mo were incubated in a 96 well multititre plate (Becton Dickinson) for 15
minutes at 37°C with either 100gl 50nm PdBu, 2mM dbcAMP or Iscove's
DMEM as control. Cells were washed twice with PBS containing 0.2% BSA
and 0.1% sodium azide and incubated at 4°C the relevant primary
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[cAMP] (pmol)
Figure 2.5. Typical standard curve obtained from cAMP radioreceptor
assay.
This is the standard curve obtained for the experiment presented in chapter 3
(section 3.3 and Fig. 3.6) and represents one of four experiments. Points
represent dpm values (mean ± S.D.) of triplicate samples.
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antibody. After 30 minutes, the cells were washed twice as before and
incubated for a further 30 minutes at 4°C with FITC-conjugated goat anti-
mouse Ig (1:25). After two further washes, cells were fixed in PBS containing
5% formaldehyde prior to flow cytometric analysis using an EPICS Profile II
flow cytometer (Coulter Electronics).
2.10. IMMUNODETECTION OF THROMBOSPONDIN.
Mo, cultured on 24 well tissue culture plates, were washed thoroughly and
treated with 0.5ml PdBu, dbcAMP or Iscove's DMEM for 15 minutes as
previously described (section 2.5.1). The cells were then washed once in
Iscove's DMEM and 200pl of Iscove's DMEM added to each well for 30
minutes at 37°C after which time the supernatant from each well was
collected. The supernatants were then concentrated approximately twenty-
fold using Centron 3 microconcentrators (Amicon Ltd., Stonehouse, U.K.) by
centrifugation in a J2-MC centrifuge (Beckman) at 7500g for one hour.
Doubling dilutions of the mo supernatants or other samples were made in
PBS and 3(il of each dilution were applied to a nitrocellulose membrane
(Anderman, Kingston-upon-Thames, U.K.) using a 20pl Gilson pipette. The
membrane was left to air dry and incubated overnight at 4°C in PBS
containing 0.2% Tween 20 (PBS-T) containing 5% non-fat dried milk. The
membrane was then washed twice in PBS-T and incubated at room
temperature with mAb against thrombospondin. After 30 minutes, unbound
mAb was removed by washing twice in PBS-T and the membrane incubated
for a further 30 minutes with peroxidase-conjugated rabbit anti-mouse Ig
(1:1000) before being washed twice more in PBS-T. The membrane was then
incubated for approximately 3 minutes in enhanced chemiluminescence
detecting reagents (Amersham International pic, Buckinghamshire, U.K.),
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excess liquid absorbed onto tissue and the nitrocellulose wrapped in
'clingfilm'. The nitrocellulose was then exposed to Hyperfilm-ECL
(Amersham) in an autoradiography cassette for 5-30 seconds prior to
development using an AGFA 242S automatic processor.
A technical complication was that using this technique, it was found that the
peroxidase-conjugated rabbit anti-mouse Ig cross reacted with serum (Fig.
2.6a.). Hence, prior to use, the antibody was preabsorbed for 60 minutes
against a piece of nitrocellulose that had been soaked in serum autologous to
the mo donor and left to air dry. As seen in figure 2.6b, this eliminated the
cross reactivity of the peroxidase-conjugated antibody.
Thrombospondin could be detected in the culture medium as shown in
figure 2.7b. Autologous serum was found to be the source of
thrombospondin in the culture medium (Fig. 2.7c). Since this might
contribute to levels of thrombospondin present in the supernatants and thus
an overestimation of the level of thrombospondin secreted, the mo were
washed thoroughly at the start of the assay with Iscove's DMEM to remove
any residual culture medium.
Serial dilutions of purified thrombospondin were also applied to the
nitrocellulose to determine the sensitivity of the assay.
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Figure 2.6. Cross reaction of peroxidase-conjugated antibody with serum.
a) Peroxidase-conjugated antibody to mouse immunoglobulin cross reaction
with serum.
b) Cross reaction of peroxidase-conjugated antibody to mouse
immunoglobulin was eliminated by exposing the antibody to serum prior to
its use in the assay.
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Figure 2.7. Thrombospondin detection in macrophage culture medium.
Thrombospondin was detected in the macrophage culture medium. The two
constituents of the culture medium, serum and Iscove's DMEM, were tested
to determine the source of thrombospondin. Serum was found to contain
thrombospondin. a) thrombospondin (pg/ml), b) macrophage culture
medium, c) serum, d) Iscove's DMEM.
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2.11.1. Receptor distribution on macrophages treated with protein kinase
activators.
Mo, recovered from Teflon foils by aspiration, were resuspended at
lxl06/ml Iscove's DMEM and 105 cells/well adhered to 2 wells of multispot
microscope slides for 1 hour at 37°C. Mo were treated with protein kinase
activators or control media for 15 minutes at 37°C then washed with Iscove's
DMEM, left to dry and fixed in acetone for 10 minutes. At this stage the
slides could be frozen and stained at a later date having been allowed
initially to defrost in acetone. Slides were then washed twice in Tris buffered
saline (TBS) and incubated at room temperature in a humid chamber with
TBS containing 20% normal rabbit serum (NRS; Scottish Antibody
Production Unit, Lanarkshire, U.K). After 10 minutes, the serum was drained
off and cells incubated for 30 minutes with primary antibody optimally
diluted in 20% NRS. The cells were then washed and blocked with 20% NRS
as before and incubated for another 30 minutes with biotinylated rabbit Ig to
mouse Ig (1:1600). After two further washes in TBS, cells were incubated for
a further 30 minutes with an avidin-biotinylated alkaline phosphate
complex. Finally, cells were incubated with the alkaline phosphate substrate
Vector Red (Vector Laboratories, Peterborough, U.K.) for 15 minutes,
washed for 5 minutes in water and dehydrated through 85%, 95% and 100%
ethanol. After clearing with xylene, slides were mounted in DPX (BDH).
Samples were viewed with an Olympus BH-2 RFCA fluorescent microscope
(Olympus Optical Co. (U.K.) Ltd, London, U.K.) and photographed with an
Olympus OM-4Ti camera using Kodak EKTAChrome 64Ti colour film.
51
2.11.2. Staining of actin on treated macrophages.
Mo adherent to multispot slides (described in section 2.11.1) were washed
with Iscove's DMEM, fixed for 5 minutes in ice-cold acetone washed in PBS
and incubated in a humid chamber for 10 minutes with PBS containing 20%
NRS. The serum was then drained off and the cells incubated with 0.15(iM
rhodamine-conjugated phalloidin (Cambridge Bioscience, Cambridge, U.K.)
in PBS containing 0.2% BSA and 0.1% sodium azide. After 20 minutes at
room temperature, the slides were washed with PBS and mounted with PBS
containing 50% glycerol.
2.11.3. Dual immunofluorescent techniques.
i) Antibody/ phalloidin staining - fixed adherent mo were washed and
blocked as described (2.11.1). Cells were then incubated for 30 minutes in
primary antibody optimally diluted in 20% NRS in PBS. The slides were then
washed in PBS, blocked again with 20% NRS and incubated with FITC-
conjugated anti-mouse Ig diluted 1:50 in 20% NRS in PBS. After 30 minutes
the cells were washed in PBS then incubated with rhodamine-conjugated
phalloidin for a further 20 minutes. Slides were washed a final time in PBS
and mounted in 50% glycerol.
ii) Receptor distribution associated with mo phagocytosis of apoptotic
neutrophils - the standard apoptotic neutrophil phagocytosis assay was
carried out as described for the multispot slides (2.5.2). Slides were fixed for
10 minutes in acetone, washed twice with TBS and then incubated for 10
minutes with 20%NRS in TBS. Immunodetection of neutrophils was
performed as follows: slides were incubated for 30 minutes with either Bob
75 or mAb29 (CD15; both IgM). These antibodies are neutrophil specific and
did not label the mo. Slides were then washed twice in TBS, blocked with
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20% NRS and incubated for a further 30 minutes with FITC-labelled affinity
purified antibody to mouse IgM (Kirkgaard and Perry Laboratories Inc.,
Maryland, U.S.A.). Slides were then labelled as described in 2.11.1. except a
goat anti-mouse IgGi biotinylated whole antibody (Amersham) was used
instead of the biotinylated rabbit Ig to mouse Ig and streptavidin-biotynlated
phycoerythrin complex (Amersham) used instead of the avidin-biotinylated
alkaline phosphate complex and Vector Red substrate.
An exception to this protocol was when LIBS1 was used as the mo primary
antibody. This mAb preferentially reacts with a site on the (53 subunit that is
expressed only after ligand binding causes the receptor to change shape
(Frelinger III et al., 1990). Therefore, the LIBS1 was present during the
phagocytosis assay and after the apoptotic neutrophils were labelled with
CD15 and FITC, the second part of the staining technique was begun with
the biotinylated IgGl-
2.12. PHAGOCYTOSIS ASSAY IN SUSPENSION.
2.12.1. Standard suspension assay.
Mo, cultured in suspension, were spun out of culture medium and incubated
at 4°C at 2xl06/ml of phycoerythrin-conjugated CD14 (PE-CD14; DAKO)
diluted 1:8 in PBS. 20 hour cultured neutrophils were spun out of the culture
medium and incubated at 37°C at 2xl06/ml of carboxyfluorescein diacetate
(CFDA: diluted 1:40000 in PBS: provided by Dr. Andrew Jackson,
Department of Surgery, University of Edinburgh, Scotland). After 30
minutes the cells were washed and resuspended in Iscove's DMEM: mo at
lxl06/ml and cultured neutrophils at 10xl06/ml. 100gl of each cell type
were added to the wells of a 96 well flexiwell plate. The cells were then
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either fixed immediately to prevent any phagocytosis occurring or incubated
for 30 minutes at 4°C or 37°C ± 5mM EDTA after which time the cells were
fixed in 5% formaldehyde and duplicate samples were analysed on an EPICS
Profile II flow cytometer. Signals from the cytometer which were red positive
(fluorescent mo) were simultaneously analysed for green fluorescence
(cultured neutrophils). For two colour work, electronic compensation was
adjusted using red only (mo) and green only (cultured neutrophils) to ensure
no false double positives were observed. Cytospins were also made of each
sample. The standard adherent phagocytosis assay was carried out in
parallel to the assay in suspension using the same labelled cells to verify the
system.
2.12.2. Isolation of apoptotic neutrophils from a mixed aged population.
For some suspension assays, the apoptotic neutrophil population was
enriched by removing the non-apoptotic aged cells. Neutrophils, cultured
overnight, were labelled with CFDA as described in 2.12 then incubated with
the antibody leu8 (CD62L [L-selectin]; IgG2b; clone SK11, Becton Dickinson)
for 30 minutes at 4°C. The cells were then washed out of the CFDA and
incubated at 4°C in Iscove's DMEM with DYNABEADS® (Dynal (U.K) Ltd,
Wirral, U.K.), previously washed twice in Iscove's DMEM at a ratio of 3
beads to every cell. After 30 minutes of continual gentle mixing, the cells
were depleted twice using a Magnetic Particle Concentrator® (Dynal (U.K.)
Ltd.). This removed the majority of non-apoptotic aged cells, increasing the
percent of apoptotic neutrophils (Fig. 2.8). The enriched apoptotic cell
population (>70% apoptotic) was then washed, recounted, resuspended at
10xl06/ml Iscove's DMEM and the suspension assay carried out as
described above (section 2.12.1). As before, a standard phagocytic assay was
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Figure 2.8. Isolation of apoptotic neutrophils from purified neutrophils
aged in culture.
Top panel: Photomicrograph of purified neutrophils aged overnight in
culture. Cultures contain a proportion of non-apoptotic cells which do not
exhibit condensed nuclei and cytoplasmic vacuoles, features characteristic of
apoptosis. Proportion of apoptotic cells prior to depletion = 47.5%.
Magnification x400.
Lower panel: Apoptotic neutrophils were enriched from the cultured
population above, by incubation of the cells with leu8 (CD62L) antibody and
subsequent removal of the non-apoptotic aged cells using DYNABEADS®.
Proportion of apoptotic cells after depletion = 73.8%. Magnification x400.
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run in parallel using the mixed aged population of neutrophils and the
enriched apoptotic population.
2.12.3. Separation of the two cell types after the suspension assay.
i) A FACStar PLUS (Becton Dickinson, Oxford, U.K.) cell sorter was used in
an attempt to separate the distinct peaks that were observed on the EPICS
profiles that might have represent phagocytic/nonphagocytic fractions.
However, because of the relatively small number of mo involved initially,
insufficient cells were obtained at the end of the sort to be conclusive.
ii) Cells were separated using a magnetic cell sorting method. Cells were
labelled with PE-CD14 and CFDA as previously described (section 2.12.1)
and incubated together at 37°C. After 30 minutes, the cells were spun down
and incubated for a further 30 minutes at 4°C in 0.5ml PBS with 75|i1 MACS
goat-anti-mouse IgG Microbeads (Eurogenetics U.K. Ltd., Teddington, U.K.)
which bind to the PE-CD14 labelled mo. The cell suspension was then
loaded onto a MiniMACS separation column, previously washed through
with PBS and placed in a MiniMACS Separation Unit (both from
Eurogenetics U.K. Ltd.). The eluant (fraction 1) was collected, and the
column washed through with 1ml and 0.5ml PBS (fractions 2 and 3
respectively). The column was then removed from the separation unit and
washed a final time with 1ml of PBS (fraction 4). Cytospins and flow
cytometer samples were made of each eluant fraction, of the cell suspensions
initially loaded onto the column and of the individual cell types involved.
To determine if the in vitro manipulations were affecting the levels of
phagocytosis in suspension, mo were labelled for 30 minutes at 4°C with
UCHM1 (CD14; 1:2) in the Teflon foils in which they were cultured. The mo
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were then gently recovered from the Teflon, spun out of the culture medium
and antibody, counted and suspended at lxl06/ml Iscove's DMEM.
Apoptotic neutrophils were not labelled but resuspended at lOxlC^/ml
Iscove's DMEM and added to Teflon foils in a ratio with the mo of 10:1. The
cell suspensions were then incubated at 37°C for 30 minutes after which
time, magnetic separation was performed. The standard phagocytosis assay
was run in parallel using the same labelled/unlabelled cells as appropriate.
2.13. STATISTICAL ANALYSIS.
All graphs display the mean ± the standard error of the mean. The Students t




There is much evidence that the molecules av(33, CD36 and thrombospondin
are involved in the recognition of apoptotic neutrophils, as described in
chapter one. However, little is known about the underlying regulatory
mechanisms of this phagocytic system. Protein kinase C and protein kinase
A have been implicated in modulating pi, P2 and P3 integrin function
(Shimizu et al., 1990; Dustin and Springer, 1989; Stupack et al., 1992
respectively). Protein kinase C (PKC) is a calcium- and phospholipid-
dependent kinase implicated in a variety of cellular responses.
Diacylglycerol, a product of phosphatidylinositol 4,5-bisphosphate
hydrolysis, activates PKC which in turn phosphorylates a range of cellular
proteins (Nishizuka, 1986). To date, nine distinct isoforms of PKC have been
identified which may have distinct biological roles (for review article, see
Hug and Sarre, 1993). PKC has been shown to be the receptor for phorbol
esters (Kikkawa et al., 1983), tumour promoters that activate PKC by
mimicking the action of diacylglycerol. The enzyme protein kinase A (PKA)
occurs as a tetramer consisting of two regulatory subunits and two catalytic
subunits bound together. The regulatory subunits each have two cAMP
binding sites and PKA has been shown to be the major intracellular receptor
for cAMP. Adenylyl cyclase catalyses the formation of cAMP from ATP. In
the absence of cAMP, the PKA complex has low activity, however, when
cAMP binds to the regulatory subunits of PKA, it promotes dissociation of
the tetramer and the enzymatic activity of the catalytic subunit markedly
increases. PKA catalyses the transfer of the terminal phosphate of ATP to
specific substrate proteins. For reviews see Soderling (1990), Taylor et al.,
(1990) and Walaas and Greengard (1991). I therefore sought to assess the
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effect of short term pretreatment of mo with activators of PKC and PKA to
determine the effect on mo recognition of apoptotic neutrophils.
3.2. EFFECT OF SHORT TERM PRE-TREATMENT OF MACROPHAGES
WITH PdBu AND dbcAMP ON RECOGNITION OF APOPTOTIC
NEUTROPHILS.
A typical light microscopy field of the phagocytosis assay performed under
control conditions is shown in figure 3.1. While most MPO-positive cells
within mo appeared intact after the standard 30 minute assay, some partially
degraded MPO-positive material was usually apparent. It was observed that
phenotypically small mo regularly phagocytosed apoptotic neutrophils
whereas there was a sub-population of giant multi-nucleated cells that
consistently did not. Levels of phagocytosis within an experiment were
reproducible between the duplicate or triplicate wells. However, because of
the variation of the levels of phagocytosis observed between experiments
(ranging from 4.7% - 59.3%, a consequence of mo donor variability), results
are expressed as a percent of the phagocytosis levels observed under control
conditions in order to allow comparison of data from different experiments.
In initial experiments, the effect of 15 minutes pre-treatment of mo with the
membrane permeable phorbol ester PdBu and the membrane permeable
analogue of cAMP, dbcAMP (activators of PKC and PKA respectively) upon
mo recognition of apoptotic neutrophils was assessed. When compared with
mo phagocytosis of apoptotic neutrophils under control conditions, pre¬
treatment of mo with 50nM PdBu increased the percent of mo ingesting
apoptotic neutrophils. In contrast, 2mM dbcAMP pre-treatment of mo
decreased the percent of cells phagocytosing apoptotic neutrophils (Fig. 3.2).
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Figure 3.1. Typical appearance of the apoptotic neutrophil phagocytosis
assay performed under control conditions.
Mo that have phagocytosed aged neutrophils can be seen to contain one or
more orange/brown MPO-positive neutrophils. Both intact and partially
degraded neutrophils are visable within the mo. A giant multinuclear mo,
typical of a sub-population that was consistently observed not phagocytose






Figure 3.2. Modulation of macrophage recognition of apoptotic
neutrophils by protein kinase activation.
Mo were pre-treated with either dbcAMP (2mM) or PdBu (50nM) for 15
minutes and then assessed for their ability to phagocytose aged apoptotic
neutrophils. In this series of experiments, 26.84 ± 4.2% (mean ± S.E.) of
macrophages phagocytosed apoptotic neutrophils under control conditions.
Activation of PKC with PdBu significantly increased the percentage of
macrophages phagocytosing apoptotic neutrophils (154% of control levels;
p<0.002; n=17) while PKA activation with dbcAMP reduced the phagocytic
response to 49% of control levels (p<0.001; n=18).
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There was no significant difference between treatments in the number of
cells counted per microscope field (data not shown) indicating that the
changes seen are not due to loss of cells as a result of incubation with PdBu
or dbcAMP.
Within individual experiments, the change in percent of phagocytosis
relative to control values as a result of treatment with PdBu or dbcAMP was
found not to be of the same magnitude (Fig. 3.3). One possibility considered
was that the level of phagocytosis under control conditions determined the
extent to which these agents exerted their effects. The results were therefore
further analysed to see if PdBu and dbcAMP were exerting their effects to a
greater extent on experiments with low or high control values respectively
(Fig. 3.4). There appears to be no correlation between the extent of inhibition
observed with dbcAMP and the level of phagocytosis occurring under
control conditions. A trend does appear to exist between PdBu induced
increase of phagocytosis and control levels. Additional experiments may
resolve this but, due to the variation in the percentage of phagocytosis
observed under control conditions as a consequence of mo donor variability,
results may not prove to be conclusive. An alternative method may be to
investigate the effects of PdBu and dbcAMP in experiments in which
different concentrations of neutrophils are added to mo monolayers.
Newman et al., (1982) have shown that the level of phagocytosis of apoptotic
cells by macrophages is dependent on the concentration of neutrophils. If the
effects of PdBu are dependent upon the strength of the phagocytic stimulus,
the relative increase in the proportion of mo that phagocytose apoptotic
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Figure 3.3. Change in phagocytosis relative to control levels within
individual experiments.
Within an experiment, the percent change in phagocytosis observed upon
treatment with PdBu or dbcAMP is not necessarily the same with respect to

















% PHAGOCYTOSIS - CONTROL
Figure 3.4. Correlation between the percent change in phagocytosis upon
treatment with the percent of phagocytosis under control conditions.
PdBu may enhance phagocytosis levels more in experiments with low counts
of phagocytosis. dbcAMP appears to inhibit mo phagocytosis of apoptotic
neutrophils to a similar degree across the range of phagocytosis levels under
control conditions (o PdBu, • dbcAMP).
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3.3. EFFECT OF THE INFLAMMATORY MEDIATOR PGE2 ON
MACROPHAGE RECOGNITION OF APOPTOTIC NEUTROPHILS.
Arachidonic acid metabolites of the prostaglandin series, in particular PGE2,
are key inflammatory mediators acting via adenylate cyclase activation and
thus elevation of intracellular cAMP. It was therefore tested whether PGE2,
like dbcAMP, would inhibit mo recognition of apoptotic cells. Treatment of
mo for 15 minutes with PGE2 plus the phosphodiesterase inhibitor IBMX
resulted in a dose-dependent inhibition of phagocytosis of apoptotic
neutrophils comparable with the levels of inhibition observed after dbcAMP
treatment (Fig. 3.5).
PGE2 has been shown to suppress macrophage function by increasing
intracellular cAMP levels (Hutchison and Myers, 1987; Bonta et al., 1981;
Bonta and Parnham, 1982). However, it has been suggested that inhibition of
macrophage phagocytosis by E-type prostaglandins is the result of a direct
effect on the cell membrane (Oropeza-Rendon et al., 1980). A cAMP
radioreceptor assay was used to determine if there was a rise in the
concentration of intracellular mo cAMP following treatment with PGE2.
Figure 3.6 shows that in this system, PGE2 causes a rise in intracellular mo
cAMP to a maximum by 2 minutes and while the concentration falls, it
remains elevated above control conditions throughout the time course of the
assay. This would suggest that PGE2 is exerting its inhibitory effect on mo
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[PGE2] + 0.5mM IBMX
TREATMENT
Figure 3.5. Effect of prostaglandin E2 on macrophage recognition of
apoptotic neutrophils.
Monocyte-derived macrophages were pre-treated with different
concentrations of PGE2 and 0.5mM IBMX and then assessed for their ability
to recognise apoptotic neutrophils. Phagocytosis under control conditions
was 16.8 + 1.3% (mean ± S.E.; n=3). Inhibition was dose-dependent with































Figure 3.6. Effect on intracellular levels of cAMP in monocyte-derived
macrophages treated with PGE2.
M0 were treated for 0.5, 2, 5,10, 15, 30 and 45 minutes with 3|iM PGE2 and
0.5mM IBMX and assayed for cAMP as described in section 2.8. Points are
the mean ± S.D. of triplicate samples and the figure represents one of four
assays. The standard curve obtained with this experiment is shown in figure
2.5.A control, OPGE 2 + IBMX.
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3.4. EFFECT OF PKC INHIBITION AND DOWN-REGULATION ON
MACROPHAGE RECOGNITION OF APOPTOTIC NEUTROPHILS.
To assess the effect that PKC inhibition would have on mo recognition of
apoptotic neutrophils, mo were treated for 15 minutes with the PKC
inhibitor H-7 (6pM; Hidaka et al., 1984). Mo were also treated for 5 minutes
with H-7 prior to being treated for 15 minutes with PdBu to determine if
PKC inhibition altered the enhanced effect that PdBu has on this phagocytic
system. Pretreatment of mo with H-7 alone had little effect on recognition of
apoptotic neutrophils when compared to control conditions. However, H-7
inhibited the 40% increase in mo recognising apoptotic neutrophils induced
by PdBu, the percent of mo recognising apoptotic neutrophils remaining
unchanged from the control value (Fig. 3.7) indicating that while activation
of PKC augments mo phagocytosis of apoptotic neutrophils, mo recognition
under standard assay conditions does not appear to be PKC dependent.
In a number of cell types, prolonged treatment with phorbol esters results in
reduced intracellular PKC concentrations (Rodriguez-Pena and Rozengurt,
1984; Stabel et al., 1987; Adams and Gullick, 1989). 50nM PdBu was prepared
in Iscove's DMEM plus 10% serum and mo were treated for 48 hours, 24
hours or 15 minutes prior to addition of apoptotic neutrophils. Mo treated
for 15 minutes with 50nM PdBu showed the characteristic increase in
phagocytosis of apoptotic neutrophils whereas treatment of mo for 24 hours
with PdBu resulted in a decrease in the percent of mo phagocytosing
apoptotic cells to 56.73% of control levels. Surprisingly, 48 hour treatment of
mo caused the percent of cells that phagocytosed apoptotic neutrophils to
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Figure 3.7. Effect of PKC inhibition on macrophage recognition of
apoptotic neutrophils.
Mo were treated for 15 minutes with either PdBu (50nM) or H-7 (6(iM) or for
5 minutes with H-7 followed by 15 minutes with PdBu. When compared to
control conditions, treatment of mo with H-7 alone has no effect on the
percent of mo recognising apoptotic neutrophils. However, the 40% increase
induced by PdBu is abolished when mo are treated initially for 5 minutes
with H-7. In this series of experiments, 34.79 ± 3.51% (mean ± S.E.) of mo
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TIME OF TREATMENT
Figure 3.8. Effect of long term pretreatment of macrophages with PdBu on
phagocytosis of apoptotic neutrophils.
Treatment of mo for 15 minutes increased the percent of mo phagocytosing
apoptotic neutrophils (202.4% of control levels; *p<0.005). Prolonged
treatment of mo with PdBu for 24 hours took phagocytic levels down to
56.73% of control values. Surprisingly, 48 hour treatment raised the percent
of mo phagocytosing apoptotic neutrophils to a level comprable with the 15
minute treatment (n=3).
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Together, these results suggest that the potential of monocyte-derived
macrophages to phagocytose apoptotic cells can be rapidly and dynamically
regulated and that modulation of protein kinase activity is associated with
regulation of mo recognition of apoptotic neutrophils.
3.5. EFFECT OF SHORT TERM PRETREATMENT OF MACROPHAGES
WITH PdBu AND dbcAMP ON RECOGNITION OF IG-OPSONISED
ERYTHROCYTES.
It was possible that protein kinase activation was exerting effects down¬
stream of the initial events in mo recognition of apoptotic neutrophils
resulting in functional alterations that would affect all mo phagocytic
processes. To investigate whether PdBu and dbcAMP had similar effects on
Ig receptor-mediated phagocytosis, similar treatment protocols were used
and the ability of mo to phagocytose Ig-opsonised erythrocytes was
assessed. In contrast to the effect of PdBu or dbcAMP on mo recognition of
apoptotic neutrophils, no enhancement or reduction of phagocytosis of Ig-
opsonised erythrocytes was observed (Fig. 3.9) suggesting that activators of
protein kinases are not acting non-specifically.
3.6. EFFECT OF PdBu AND dbcAMP ON MACROPHAGE SURFACE
EXPRESSION OF av(33 AND CD36.
All mo express av(33 and CD36 (Fig. 3.10). Using flow cytometry I next
examined whether altered mo functional capacity in response to activating
stimuli involved altered expression of these receptors. Although control and
treated mo expressed CD51 (av), CD61 ((33) and CD36 (Fig. 3.10), no








Figure 3.9. Effect of dbcAMP and PdBu on macrophage phagocytosis of Ig-
opsonised erythrocytes.
Mo were treated with 2mM dbcAMP or 50nM PdBu for 15 minutes prior to
assessment of their ability to phagocytose Ig-opsonised erythrocytes. In
contrast to the effects of these reagents on apoptotic neutrophil phagocytosis,
no significant change in Fc-mediated phagocytosis was observed (PdBu, n =
3; dbcAMP, n = 5). Under control conditions, 34.15 ± 11.55% (mean ± S.E.) of
the mo recognised Ig-opsonised erythrocytes.
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Figure 3.10. Expression of av(33 and CD36 on treated and untreated
macrophages.
Monocyte-derived macrophages were pre-treated with protein kinase
activators dbcAMP and PdBu or Iscove's DMEM as control for 15 minutes
and examined for expression of avp3 and CD36 expression by flow
cytometry. Representative fluorescence histograms from one of three







fluorescence intensity, was observed following pre-treatment with protein
kinase activators (Table 3.1). These data suggest that the effect of protein
kinase activators on mo recognition of apoptotic cells does not occur as a
result of modulation of the surface expression of the receptors involved in
the recognition process.
3.7. ROLE OF THROMBOSPONDIN IN MACROPHAGE
PHAGOCYTOSIS OF APOPTOTIC NEUTROPHILS.
As the levels of expression of av(33 and CD36 were not affected I next
considered whether alteration in PKC or A activity affected the extracellular
matrix molecule that has been suggested to act as a bridge between the av(33
and CD36 present on the mo surface and the apoptotic cell, mo secreted
thrombospondin (Savill et al., 1992).
3.7.1. Effect of PdBu and dbcAMP on the levels of thrombospondin
secreted by macrophages.
Thrombospondin has been shown to be present in the assay medium after
mo have been co-incubated with apoptotic neutrophils (Savill et al., 1992). A
sensitive dot blot assay using mAb to two distinct epitopes of
thrombospondin (detection limit < 0.05pg/ml of thrombospondin) was used
to measure thrombospondin present in supernatants obtained from treated
mo. It was found that extensive washing of mo was necessary to remove
thrombospondin present in the culture medium (Fig. 2.7). The supernatants,
isolated from untreated mo or mo pre-treated with either PdBu or dbcAMP
for 15 minutes, washed and cultured for 30 minutes in medium alone, were
tested for the presence of thrombospondin. However, somewhat
surprisingly, thrombospondin could not be detected in supernatants from
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Experiment Antibody Control PdBu dbcAMP
1 3.2 3.8 4.4
2 13C2 3.9 3.9 3.8
3 9.6 7.8 9.4
1 3.6 4.1 3.8
2 23C6 3.3 4.9 5.0
3 5.8 4.3 5.3
1 6.2 4.8 5.6
2 SM0 3.8 5.1 8.9
3 3.1 3.3 3.7
Table 3.1. Mean fluorescent values for expression of the vitronectin
receptor and CD36 on the surface of control and treated macrophages.
Values are the mean of duplicate samples and comparison of the mean
fluorescence of each molecule following PdBu or dbcAMP treatment reveals
no significant change in receptor expression from control levels in any of the
experiments performed. Mean ± S.D. of mean fluorescent values for control
mAb : experiment 1 = 1.9± 0.1, experiment 2 = 2.5 ± 0.2, experiment 3 = 1.4 ±
0.1
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either control or treated mo, even when concentrated 20-fold (Fig. 3.11).
Similar results were obtained with another mAb, MA-IV, to a different
domain of thrombospondin (data not shown). The fact that thrombospondin
could not be detected in medium under control conditions and that protein
kinase activation did not induce thrombospondin secretion questions the
role of secreted thrombospondin in the phagocytosis of apoptotic
neutrophils.
3.7.2. Effect of PdBu and dbcAMP on levels of macrophage surface-bound
thrombospondin.
Since protein kinase activation does not cause alterations in the levels of
surface expression of mo receptors or in the levels of thrombospondin
secreted by mo, the altered functional activity caused by the protein kinase
activators might alter levels of thrombospondin bound to the surface of the
mo. Using indirect immunofluorescence flow cytometry, the level of surface-
bound thrombospondin was analysed. In order to avoid problems of
possible masking of epitopes on surface-bound thrombospondin, two mAb
with distinct epitope specificites were used (MA-I binds to the type HI repeat
regions of thrombospondin and MA-IV binds to the heparin binding domain
of thrombospondin). However, there was no significant change in the
amount of thrombospondin bound to the surface of the mo as assessed by
mean fluorescent values of treated and untreated mo (Fig. 3.12). These
results demonstrate that protein kinase activation does not alter binding of
thrombospondin to the mo surface and strongly suggest that modulation of
mo recognition of apoptotic cells occurs independently of alterations of mo
surface expression of avP3 and CD36 and mo secretion and/or binding of
thrombospondin.
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Figure 3.11. Effects of protein kinase activators on secretion of
thrombospondin by macrophages.
Supernatants obtained from mo pre-treated with PdBu or dbcAMP were
concentrated 20-fold and serial dilutions dotted onto nitrocellulose. The
membrane was then probed with mAb MA-I specific for thrombospondin
and bound mAb visualized with peroxide-conjugated-anti-mouse Ig
antibody using enhanced chemiluminescence detection reagents and
autoradiography. Assay detection limit <0.05jug/ml of thrombospondin.
a) thrombospondin (f/g/ml) b) medium control c) PdBu d) dbcAMP.
80
3.25 7.5 15 30 60 120 1200





Figure 3.12. Effects of protein kinase activation on levels of
thrombospondin bound to the macrophage surface.
The levels of surface-bound thrombospondin on untreated mo or following
pre-treatment with protein kinase activators was assessed by flow
cytometry. Mo were pre-treated for 15 minutes with control media (black
bars), PdBu (grey bars) or dbcAMP (white bars). Antibodies against the type
III repeats, MA-I, and the heparin binding domain, MA-IV, of
thrombospondin were used to detect any change in surface bound
thrombospondin. No significant change in the amount of surface bound
thrombospondin was observed upon activation of PKC or PKA (n=3).
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3.8. EFFECT OF PROTEIN KINASE ACTIVATORS ON MACROPHAGE
RECEPTOR DISTRIBUTION.
Another possible mechanism for the observed effects of protein kinase
activators upon mo recognition of apoptotic neutrophils is that the
membrane distribution of receptors involved in the recognition process
could be altered without changes in the number or affinity of the receptors
expressed on the mo surface. Using the mAbs PM6/13 (1:50) against the
vitronectin receptor (33-subunit and FA6-125 (1:100) against the CD36
thrombospondin receptor, the cellular distribution of these receptors on mo
pre-treated with dbcAMP or PdBu for 15 minutes was examined using
indirect immunofluorescence microscopy. In keeping with data from flow
cytometric analysis, all monocyte-derived macrophages were found to
express (33 and CD36. The distribution of CD36 was found to be similar on
mo treated with PdBu and dbcAMP (Fig. 3.13a and b respectively).
However, heterogeneity in terms of the pattern of distribution of the (33
subunit was observed in both untreated and treated mo populations. For
some mo, a distinct "punctate" distribution of (33 (Fig. 3.13c) was readily
distinguished from a uniform distribution (Fig. 3.13d). It was therefore
assessed whether pre-treatment of mo with either PdBu or dbcAMP altered
the proportions of mo which had these staining patterns. Comparison of (33
distributions in PdBu-treated and cAMP-treated mo revealed that dbcAMP
reduced the percentage of mo with a punctate (33 distribution (see Table 3.2).
Protein kinase activation may therefore serve to modulate the mo phenotype
in terms of cellular distribution of the integrin av(33, thereby regulating
recognition of apoptotic neutrophils.
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Figure 3.13. Effect of protein kinase activation upon distribution of
receptors on the macrophage surface.
Mo, pretreated with PdBu and dbcAMP, were fixed and stained with mAb
against CD36 or the (33 subunit to determine if activation of PKC or PKA
altered the distribution of the receptors involved in mo recognition of
apoptotic neutrophils. Typical distributions observed for CD36 on mo
treated with either PdBu or dbcAMP are shown (a and b respectively). Two
distinct patterns of (33 distribution were observed, with a distinct 'punctate'




Experiment TREATMENT % change
number PdBu dbcAMP dbcAMP/PdBu
1 31.9 26.8 16.0
2 37.1 19.2 48.3
3 19.4 10.6 45.5
Table 3.2. Percent of monocyte-derived macrophages with punctate
PM6/13 ((33) staining pattern following pre-treatment with the protein
kinase activators PdBu and dbcAMP.
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3.9. SUMMARY OF RESULTS.
Activation of PKC by treatment with PdBu up-regulates mo recognition of
apoptotic neutrophils while PKA activation by dbcAMP causes down
regulation of recognition. Within an experiment, the change in phagocytosis
between PdBu and dbcAMP treatments, relative to controls, is not
necessarily of the same magnitude and results suggest that PdBu may
increase the percent of mo phagocytosing apoptotic neutrophils more in
experiments in which there is a low level of phagocytosis in untreated cells.
In contrast, dbcAMP appears to inhibit to a similar degree irrespective of the
amount of phagocytosis in control conditions.
The inflammatory mediator PGE2 reduces phagocytosis of apoptotic
neutrophils by elevating intracellular mo cAMP. Inhibition of PKC with H-7
alone does not affect the percent of mo recognising apoptotic neutrophils.
However, H7 does inhibit the enhanced phagocytosis induced by PdBu
treatment. Prolonged treatment of mo for 24 hours with PdBu reduces the
percent of mo recognising apoptotic neutrophils. Unexpectedly however, 48
hour treatment of mo with PdBu causes in an increase in the number of mo
phagocytosing apoptotic neutrophils.
The effect of PKC and PKA activation appears to be specific for this
phagocytic system as no change in phagocytosis of Ig-opsonised
erythrocytes is observed upon pretreatment of mo with PdBu or dbcAMP
and changes in recognition levels occur without altered av[33 or CD36
expression on the surface of the treated mo. Thrombospondin could not be
detected in the medium from treated or untreated mo and activation of PKC
or PKA does not alter the amount of thrombospondin bound to the surface
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of the mo. Finally, treatment with PdBu and dbcAMP altered the distribution
of mo (33 but not CD36.
3.10. DISCUSSION
The control mechanisms that underlie mo recognition, phagocytosis and
removal of apoptotic cells from inflamed sites are central to our
understanding of the control of inflammation and the processes by which it
resolves. Perturbation of the balance between neutrophil recruitment from
the circulation, phagocytic removal of apoptotic neutrophils by macrophages
(or other phagocytes) and neutrophil disintegration or necrosis may
determine whether inflammation resolves or progresses to the chronic
inflammatory states associated with most inflammatory diseases. However,
since some macrophage populations (e.g. giant cells and alveolar
macrophages) are relatively inefficient at phagocytosing apoptotic cells,
microenvironment-dependent phenotypic alterations during differentiation
may also regulate this process (Rutherford et al., 1993). Evidence to date
suggests that binding and subsequent phagocytosis of apoptotic neutrophils
by mo requires both CD36 and av(33. However, although all mo express
these molecules (Fig. 3.9), not all mo respond to the stimulus of apoptotic
cells by phagocytic uptake. Therefore, expression is necessary but not
sufficient for all mo to ingest apoptotic neutrophils. This observation implies
that further regulatory mechanisms exist.
Here, it has been demonstrated that modulation of protein kinase activity
has the potential to alter the ability of monocyte-derived macrophages to
recognise and phagocytose apoptotic neutrophils thereby providing a rapid,
subtle response to micro-environmental stimuli. Activators of PKA were
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found to reduce the percentage of mo phagocytosing apoptotic cells,
whereas activators of PKC increased the proportion of responding mo.
Treatment with the PKC inhibitor H-7 caused no change in the level of
phagocytosis when compared to control conditions. However the PdBu-
induced response was ablated by H-7 , suggesting that mo phagocytosis of
apoptotic neutrophils is not PKC dependent. Treatment of mo for 24 hours
with PdBu (down-regulating PKC) reduced the number of mo
phagocytosing apoptotic neutrophils seemingly contradicting the H-7 and
PdBu results. However, total inhibition was not achieved following 24 hour
treatment and 48 hour treatment of mo saw phagocytosis levels, relative to
control, comparable with that seen after 15 minutes of PdBu treatment. With
respect to PKC down-regulation, different PKC isoenzymes are reported to
react differently within a single cell type (Ase et al., 1988) and between cell
types (Adams and Gullick, 1989). Knowledge of the PKC isoforms involved,
use of more specific PKC inhibitors and quantification of PKC upon phorbol
ester treatment (Stabel et al., 1987) could help clarify the role of PKC in mo
phagocytosis of apoptotic neutrophils.
Although it is possible that all monocyte-derived macrophages are capable
of phagocytosing apoptotic cells providing that a certain activation
"threshold" is reached, the increase in the percentage of mo phagocytosing
apoptotic cells following phorbol ester treatment was ~150% of control
levels, suggesting the system could be responsive to stimulants other than
PKC activators. Alternatively, some mo may be unable to respond to the
apoptotic cell stimulus. In support of this argument, it has been observed
that some mo sub-populations (notably multi-nucleated giant cells, Fig. 3.1)
may be particularly inefficient at phagocytosis of apoptotic neutrophils.
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The above observations may be of great significance for removal of apoptotic
neutrophils in situ. A variety of inflammatory mediators including TNF and
many cytokines (IL8, C5a, fMLP) ultimately simulate PKC activity and may
increase apoptotic cell removal, whereas agents which stimulate adenyl
cyclase activity and activate PKA (Aderem, 1993) could possibly decrease
apoptotic cell removal. Inflammatory mediators may have complex effects
upon leukocyte function in terms of resolution of inflammation. Treatment
of mo with PGE2 inhibited subsequent recognition of apoptotic cells thereby
reducing macrophage potential for phagocytic removal of apoptotic cells.
One consequence of this might be that although PGE2 acts as an "anti¬
inflammatory" agent in terms of neutrophil function at inflamed sites, an
increased proportion of neutrophils may progress from apoptosis to necrosis
which would result in an increased potential for local tissue damage and
prolongation of the inflammatory response.
In keeping with previous observations (Newman et al., 1991), phorbol ester
and dbcAMP treatment of human monocyte-derived macrophages had no
effect on Fc receptor-mediated phagocytosis suggesting the effects of PKC
and PKA activation are acting specifically on the apoptotic neutrophil
phagocytic system. Protein kinase activation did not alter mo expression of
av(i3 or CD36 or mo surface bound thrombospondin. It is of interest that
phorbol ester treatment induces CD36 expression on the U-937 macrophage
cell line (Talle et al., 1983). Thrombospondin (0.59|ig/ml) has previously been
detected in the assay medium following mo phagocytosis of apoptotic
neutrophils (Savill et al., 1992). Using a detection technique, 1000 times more
sensitive than that previously used, thrombospondin could not be detected
in concentrated supernatants from either control or treated mo. The
supernatants tested for the presence of thrombospondin were obtained in the
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absence of apoptotic neutrophils and it is possible that apoptotic neutrophils
act as a stimulus to induce thrombospondin production by mo.
Alternatively, results presented in this thesis suggest that thrombospondin
detected by Savill and colleagues (1992) could be residual serum from the
mo and neutrophil culture media (Fig. 2.7a) which I have found requires
extensive washing to remove completely. That phagocytosis occurs in the
absence of detectable amounts of secreted thrombospondin questions the
bridging role suggested by Savill et al. (1992) for mo-synthesised
thrombospondin in phagocytosis of apoptotic neutrophils.
The av|33 integrin mediates adhesion to substrates (Wayner et al., 1991;
Charo et al., 1990; Smith et al., 1990) and promotes migration on ECM
components (Leavesley et al., 1993). PKC regulates the function of av(33
independently of alterations of surface expression in some B cell lines
(Stupack et al., 1992). Regulation of focal contact formation and co-
localisation of vinculin and talin with clusters of integrin receptors occurs in
a PKC-dependent manner (Woods and Couchman, 1992), possibly as a result
of direct phosphorylation of integrin subunits (Freed et al., 1989).
Interestingly, for cell lines that express both av(33 and avp5, only av(33
becomes associated with focal contacts and not av(35 (Woods and
Couchman, 1992). The distribution of the av(33 integrin and CD36 on mo
following pre-treatment with protein kinase activators was therefore
examined.
In treated mo, no alterations in receptor distribution of either CD36 or a
number of integrin a-subunits including av, a5, and apl50,95 were noted
(not shown). In contrast, for a subpopulation of mo, altered distribution of
the integrin (33-subunit was observed. These changes occurred in parallel
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with changes in the percentage of mo phagocytosing apoptotic cells
following pre-treatment with these agents. Thus, homogeneous distribution
of av(33 was associated with low levels of mo phagocytosis, whereas a
punctate distribution was associated with higher levels of phagocytosis.
Taken together, results presented in this chapter suggest that receptor
redistribution may provide a mechanism for increased avidity of binding via
avp3 which results in enhanced mo recognition of apoptotic cells.
In summary, I have shown that short term treatment of mo with protein
kinase activators modulates mo recognition of apoptotic cells. These are
observations which may have significant functional in vivo implications since
a variety of mediators likely to be present at inflamed sites have proven
capacity to influence these pathways. Modulation appears to be specific for
this phagocytic system and is independent of changes in expression of the
receptors implicated in the recognition process or modulation of
thrombospondin production/binding by mo. A specific, rapid redistribution
of av[33 was observed in treated mo which may be related to the alteration in
the percentage of mo which are able to recognise apoptotic cells. It is
reasonable to speculate that rapid redistribution of avp3 on the surface of the
macrophage may play a role in regulatory mechanisms that underlie




The cytoskeleton of the macrophage consists of a three-dimensional
network of actin filaments and associated proteins (Yin and Hartwig,
1988: Baba et al., 1991). Communication between the cytoskeleton and the
ECM is via integrins which provide a trans-membrane link (Tamkun et
al., 1986). At sites of cell-ECM or cell-cell adhesion, the integrin (3-subunit
cytoplasmic domain has been shown to indirectly associate with the actin
skeleton via cytoskeletal proteins such as talin (Horwitz et al., 1986:
Tapley et al., 1989) and a-actinin (Otey et al., 1990). Talin and a-actinin
binding to integrin is a low affinity interaction (10~6 to 10_7M). a-subunits
have different cytoplasmic sequences and different integrin receptors for
the same ligand can differ in apparent associations with the cytoskeleton
(Wayner et al., 1991: Elices et al., 1991) suggesting that the a-subunit may
regulate the types of interaction that the P-subunit cytoplasmic tail can
have with its cytoskeletal binding sites. Evidence suggests ligand-induced
regulation of focal adhesion localisation, the a-subunit serving to interact
(directly/indirectly) with sites on the P-subunit (Ylanne et al., 1993).
Ligation would propagate a conformational change that allows the (3-
subunit cytoplasmic domain to interact with cytoplasmic molecules
giving rise to discrete intracellular functions (for review see Sastry and
Horwitz, 1993). Since results presented in the previous chapter
demonstrated altered P3 distribution associated with modulation of mo
recognition, dual immunofluorescence techniques were used to
investigate if there was association of mo avP3 with mo cytoskeletal
components and to assess the effect that PKC and PKA activation might
have on such interactions.
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4.2. ASSOCIATION OF TALIN BUT NOT INTEGRIN (33 SUBUNIT
WITH THE MACROPHAGE ACTIN CYTOSKELETON AND THE
EFFECT OF PROTEIN KINASE ACTIVATION.
M0, treated for 15 minutes with PdBu, dbcAMP or Iscove's DMEM as
control, were fixed and double-stained for either the vitronectin receptor
[3 subunit ((33), talin or vinculin (a cytoplasmic protein that interacts with
talin) (Burridge and Mangeat, 1984), and for F-actin. The distribution of
the (33 subunit, cytoskeletal proteins and actin was examined by indirect
immunofluorescence microscopy and confocal microscopy.
Mo treated with Iscove's DMEM and PdBu exhibited a network of actin
filaments often traversing the cell (Fig. 4.1 and 4.2 respectively) and
terminating at the substrate-associated side of the cell at small focal
adhesions, characterised by the presence of talin (Fig. 4.3) and vinculin
(not shown). In mo treated with dbcAMP, most of the of longer actin
filaments had disappeared and the actin was observed as short, irregular
appearing aggregates, the majority concentrated within the body of the
cell (Fig. 4.4). Confocal microscopy still showed association of talin (and
vinculin) with actin however, dbcAMP treatment caused the discrete
colocalisation seen in control and PdBu treated cells to disappear and a
diffuse staining pattern to form (Fig.4.3). Thus, one effect of dbcAMP was
to alter mo actin cytoskeletal architecture. However, av(33 is not
specifically localised at sites of actin foci, which contain talin and
vinculin. This suggests that av(33 is not involved in the regulation of mo
cytoskeletal organisation.
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Figure 4.1. (Top panel) Actin distribution of untreated macrophages.
Unterated mo, adhered for 75 minutes in Iscove's DMEM, were fixed and
stained with rhodamine-conjugated phalloidin. A prominent system of actin
filaments are seen to traverse the cell and terminate in punctate structures at
the substrate-associated surface of the mo. Magnification xlOOO.
Figure 4.2. (Lower panel) Actin distribution of macrophages treated with
PdBu.
Mo, adhered for 60 minutes in Iscove's DMEM, were treated for 15 minutes
with PdBu (50nM), fixed and stained with rhodamine-conjugated phalloidin.
Both linear and punctate structures are visible comparable to those observed
in untreated mo (Fig. 4.1). Magnification xlOOO.
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Figure 4.3. Distribution of actin and talin of untreated macrophages and
macrophages treated with dbcAMP.
Dual fluorescence confocal microscopy shows the relationship between talin
and the mo actin cytoskeletal framework. In control cells (and PdBu treated
mo, not shown) actin is seen to terminate in focal adhesions, as determined
by the presence of talin (and vinculin, not shown). Treatment with dbcAMP
causes disruption of focal contacts resulting in actin and talin co-localising in





Figure 4.4. Actin distribution of macrophages treated with dbcAMP.
Actin filaments, observed in control and PdBu treated mo to terminate at the
substrate-associated side of the cell, are not apparent in mo treated with
dbcAMP (top panel). Instead, the majority of actin appears concentrated




4.3. ROLE OF THE INTEGRIN av(33 IN MACROPHAGE PHAGOCYTOSIS
OF APOPTOTIC NEUTROPHILS.
As a consequence of the observed effects of protein kinase activators on
the mo actin cytoskeleton and the fact that the vitronectin receptor was
not seen to associate with actin, I re-examined the role of the vitronectin
receptor in the phagocytosis of apoptotic neutrophils.
4.3.1. Antibodies against the integrin av|33 do not inhibit macrophage
phagocytosis of apoptotic neutrophils.
Mo, cultured in suspension and adhered for 60 minutes to 96 well plates
or multispot microscope slides, were treated with saturating
concentrations of mAb against av and av(33 for 20 minutes and assessed
for phagocytosis of apoptotic neutrophils as described in 2.7.2i. A mAb
against CD36 was also tested. These mAb have previously been shown to
bind to mo (Fig. 3.9) however, preincubation of mo with mAb against the
vitronectin receptor or CD36 caused no significant change in the levels of
phagocytosis when compared to control levels (Fig. 4.5).
In addition to the mAb against av (CD51) and av(33 (CD51/CD61), a panel
of mAb against CD61 (the (33-subunit) was obtained from the Vth
International Workshop on Leukocyte Differentiation Antigens and
tested in the apoptotic neutrophil phagocytosis assay. All of these mAb
were shown to bind to mo by flow cytometric analysis (Fig. 4.6) however,
in keeping with previous data, little change was observed in phagocytosis
relative to control levels (Fig. 4.7).
101
CONTROL 13C2 23C6 SM0
TREATMENT
Figure 4.5. Effect of monoclonal antibodies against the av(33 vitronectin
receptor and CD36 on macrophage phagocytosis of apoptotic neutrophils.
Mo were treated for 20 minutes at room temperature with mAb against
av (13C2; 1:50; n= 5), avp3 (23C6; 1: 50; n=4) and CD36 (SM0; 1:25; n=3)
prior to assessment of their ability to phagocytose apoptotic neutrophils.
Preincubation of mo with mAb caused no significant change in
phagocytosis levels when compared to control. In this set of experiments,









Figure 4.6. Expression of CD61 (P3-subunit) on human monocyte-derived
macrophages.
The expression of the vitronectin receptor P3-subunit was assessed by
flow cytometry using a panel of CD61 mAb. Results are expressed as the







Figure 4.7. Effect of a panel of CD61 monoclonal antibodies on
macrophage phagocytosis of apoptotic neutrophils.
Mo were incubated for 20 minutes with one of eight mAb against CD61
(the (33-subunit) and their ability to phagocytose apoptotic neutrophils
assessed. Compared to control values, preincubation of mo with anti-
CD61 mAb had no significant effect on phagocytosis levels. 20.22 ± 5.4%
(mean ± S.E.) of mo in control conditions recognised apoptotic
neutrophils.
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4.3.2. Distribution of macrophage avp3 integrin during phagocytosis of
apoptotic neutrophils.
Following on from the observation that the P3-"subunit does not
colocalise with actin and that mAb against the vitronectin receptor do not
inhibit phagocytosis, the distribution of av^3 during phagocytosis of
apoptotic neutrophils was investigated. The standard apoptotic
neutrophil phagocytosis assay was carried out on multispot microscope
slides, fixed and double stained for apoptotic neutrophils and mo CD36
(SM0; 1:25), avp3 (LM609; 1:250) and p3 (PM6/13; 1:50) as described in
2.11.3ii. Distribution of mo receptors and apoptotic cells were then
assessed by indirect immunofluorescent microscopy.
No co-localisation of mo receptors with the apoptotic neutrophils was
observed using the above mAb. In addition, the mAb LIBS1, which
preferentially binds to a site exposed on the p3 integrin subunit when the
receptor has been bound by ligand (Frelinger III et al., 1990), was used. As
the binding site for this mAb is exposed upon ligand binding, it was
considered necessary, in these experiments, to add LIBS1 during the
phagocytosis assay. Figure 4.8 shows the LIBS1 staining pattern of mo
involved in an apoptotic neutrophil phagocytosis assay and the same
field of view stained for neutrophil location. Observations from repeated
experiments failed to provide conclusive evidence for mo P3 co-
localisation with apoptotic neutrophils.
These results, along with the data presented in chapter 3 (section 3.7.1.),
question the molecular mechanism for recognition of apoptotic
neutrophils by macrophages proposed by Savill and co-workers (Savill et
al., 1990 and 1992). Using a sensitive detection technique,
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Figure 4.8. Distribution of macrophage (33-subunit during phagocytosis of
apoptotic neutrophils.
Dual immunofluorescent staining was used to assess the distribution of mo
(33-subunit during mo phagocytosis of apoptotic neutrophils. The mAb
LIBS1 was used to show the location of the (33-subunit (top panel). The
position of apoptotic neutrophils in the same field of view is also shown
(lower panel). Magnification x400.
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thrombospondin could not be detected in macrophage supernatants and
several mAb against CD36 and the vitronectin receptor subunits do not
affect the level of phagocytosis relative to control conditions. Finally, no
co-localisation of av(33 and apoptotic neutrophils could be observed.
4.4. EFFECT OF OTHER INHIBITORS OF MACROPHAGE
PHAGOCYTOSIS OF APOPTOTIC NEUTROPHILS ON THE
MACROPHAGE CYTOSKELETON.
Since dbcAMP was found to affect the mo cytoskeleton, I next considered
whether mo cytoskeletal structure was affected following treatment with
other compounds that have, in this thesis and in previous studies (Savill
et al., 1989 and 1990), been reported to inhibit phagocytosis of apoptotic
neutrophils.
As described in chapter 3, PGE2 has been shown to reduce mo
phagocytosis of apoptotic neutrophils to 49.57 ± 5.51% (mean ± S.E.) of
control values. As seen in figure 4.9, treatment of mo with PGE2 causes
disruption of the actin cytoskeleton similar to that seen after dbcAMP
treatment and is consistent with the observed elevation of intracellular
cAMP following PGE2 treatment.
Savill et al. (1990) reported specific inhibition of phagocytosis of apoptotic
neutrophils by the tetrapeptide RGDS. No disruption of the actin
cytoskeleton was observed in mo incubated with the RGDS peptide (Fig.
4.10) and RGDS did not inhibit phagocytosis when added to the apoptotic
neutrophil assay (Fig. 4.11), supporting further my previous observations
that question the direct involvement of the av(33 integrin receptor.
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Figure 4.9. Actin distribution of macrophages treated with PGE2.
Top panel: Untreated mo, adhered for 75 minutes in Iscove's DMEM, fixed
and stained with rhodamine-conjugated phalloidin. Magnification x400.
Lower panel: Mo, adhered for 60 minutes in Iscove's DMEM were treated for
15 minutes with PGE2 (3pM), fixed and stained with rhodamine-conjugated




Figure 4.10. Actin distribution of macrophages incubated with the
tetrapeptide RGDS.
Top panel: Untreated mo, adhered for 90 minutes in Iscove's DMEM, fixed
and stained for F-actin. Magnification xlOOO.
Lower panel: Mo, adhered for 60 minutes in Iscove's DMEM and incubated a
further 30 minutes with the tetrapeptide RGDS (ImM), were fixed and
stained for F-actin. As seen in control cells, mo incubated with RGDS display


























Figure 4.11. Effect of the tetrapeptide RGDS on macrophage phagocytosis
of apoptotic neutrophils.
The presence of the RGDS peptide (ImM) during the phagocytic assay had
no significant effect on the level of phagocytosis when compared to
control conditions. 22.06 ± 4.5% (mean ± S.E.) of mo phagocytosed
apoptotic neutrophils under control conditions. n=3.
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Phagocytosis of apoptotic neutrophils is dependent on Mg2+ and Ca2+
(Savill et al, 1990). Addition of EDTA (5mM) to the phagocytosis assay
inhibits mo phagocytosis by almost 100% (Fig. 4.12) however, a change in
the staining pattern of the actin cytoskeleton is observed after 30 minutes
treatment of mo with EDTA (Fig. 4.13). Actin dense areas can be seen
around the periphery of cells and cell contact appears to have been lost.
4.5. SUMMARY OF RESULTS.
In untreated and PdBu treated mo, the cytoskeletal proteins talin and
vinculin colocalise with actin at the end of stress fibres in focal contacts.
Treatment of mo with dbcAMP results in disruption of the mo stress fibre
network although talin and vinculin are still seen to associate with the
actin. No colocalisation of the P3-subunit is observed with the ends of the
actin network and avP3 cannot be shown to localise with apoptotic
neutrophils during the phagocytosis assay. Furthermore, mAb against
avp3 and CD36 did not inhibit mo phagocytosis of apoptotic neutrophils.
Other inhibitors of macrophage phagocytosis of apoptotic neutrophils
(PGE2 and EDTA) were shown to disrupt the macrophage actin
framework. The tetrapeptide RGDS did not alter the percent of
macrophages phagocytosing apoptotic neutrophils and did not cause







Figure 4.12. Effect of EDTA on macrophage phagocytosis of apoptotic
neutrophils.
The standard phagocytosis assay was carried out in the presence of 5mM
EDTA. Phagocytosis was inhibited to 5.96% of control levels. In this set of
experiments, 21.36 ± 6.1% (mean ± S.E.) of mo phagocytosed apoptotic
cells (p<0.001; n = 3).
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Figure 4.13. Actin distribution of macrophages treated with EDTA.
Top panel: Untreated mo, adhered for 75 minutes in Iscove's DMEM, fixed
and stained with rhodamine-conjugated phalloidin. Magnification x400.
Lower panel: Mo, adhered for 60 minutes in Iscove's DMEM and treated a
further 30 minutes with EDTA (5mM) were fixed and stained for F-actin.
Actin dense areas at the periphery of the cells are apparent when compared




In this chapter, the effect of protein kinase activation on the actin
cytoskeleton and associated cytoskeletal proteins of monocyte-derived
macrophages has been investigated. Untreated control cells and mo
treated for 15 minutes with PdBu contain a prominent system of actin
filaments, crossing the main body of the mo in roughly parallel arrays,
associated with the substrate side of the cell. The cytoskeletal proteins
actin and vinculin were found to associate with the ends of these actin
filaments at small focal contacts. Treatment of mo with dbcAMP resulted
in the disruption of the actin filaments into smaller aggregates found
more within the cell body and while talin and vinculin were still found
to colocalise with the actin there was no sign of the focal adhesion points
seen in control cells and those treated with PdBu.
The response to phorbol esters and dbcAMP tends to be dependent on the
cell type being studied. Previous studies have reported that in certain cell
types, PKC activators strongly promote cell spreading (Petty, 1989; Grant
and Aunis, 1990) and adhesion (Danilov and Juliano, 1989; Gladwin et al.,
1990), actin assembly (Phaire-Washington et al., 1980) and the
development of stress fibres (Grant and Aunis, 1990) and focal adhesions
(Woods and Couchman, 1992). However, these are in contrast to other
reports demonstrating disruption of the actin cytoskeleton upon phorbol
ester treatment (Schliwa et al., 1984; Kellie et al., 1985; Sobue et al., 1988;
Danowski et al., 1988; Turner et al., 1989; Ciesieski-Treska et al., 1991).
Likewise dbcAMP treatment is reported to have diverse effects depending
on cell type, disrupting the aclin cytoskeleton integrity and impairing
adhesion of various cell types (Hamachi et al., 1984; Lamb et al., 1988,
Petty and Martin, 1989; Turner et al., 1989; Lampugnani et al., 1990;
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Goldman and Abramson, 1990; Valitutti et al., 1993; Glass and Kreisberg,
1993) and yet promoting cell spreading and adhesion in others (Leader et
al., 1983; Cheung and Juliano, 1985).
In guinea-pig peritoneal macrophages, Hamachi et al. (1984) showed that
dbcAMP promotes actin disassembly. Petty and Martin (1989) observed a
decrease in cell spreading and rearrangement of the actin skeleton in the
murine macrophage cell line RAW264 when treated with dbcAMP.
Furthermore, Petty (1989) reports that treatment of RAW264
macrophages with activators of PKC increases cell spreading, probably
mediated by the cytoskeleton, and that simultaneous dbcAMP treatment
inhibits the PKC induced effects. These results lead Petty to suggest a bi¬
directional control system regulating macrophage spreading whereby
PKA provides a negative regulatory signal to the PKC pathway. This
would be in keeping with preliminary data obtained for simultaneous
treatment of mo with PdBu and dbcAMP. In this case, phagocytosis levels
were on a par with the separate dbcAMP treatment. As different cell types
exhibit different functions and modes of interaction for PKC and PKA
(Kikkawa and Nishizuka, 1986), it would be valuable to pursue this
observation further to determine if such a control mechanism proposed
by Petty exists for mo phagocytosis of apoptotic neutrophils.
Talin and vinculin have been shown to be phosphorylated (Litchfield
and Ball, 1986; Werth et al., 1983; Kawamoto and Hidaka, 1984) raising the
possibility that phosphorylation status may regulate association with the
cytoskeleton. However, in keeping with effects of protein kinase
activators on actin organisation, talin phosphorylation by activation of
PKC appears to be cell type specific. Turner et al. (1989) found that in BSC-
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1 cells, talin phosphorylation accompanied stress fibre disruption whereas
there was no change in the phosphorylation state of talin or disruption of
stress fibres in REF-52 cells treated with phorbol ester. However, they did
observe low levels of dephosphorylation of talin and disruption of stress
fibres occurred in REF-52 cells when treated with dbcAMP but suspect that
an alternative mechanism is responsible for cytoskeletal disruption.
Lamb et al. (1988) demonstrate that dbcAMP treatment and
microinjection of the catalytic subunit of A-kinase results in
phosphorylation of myosin light chain kinase (MLCK), causing
inactivation of MLCK, subsequent dephosphorylation of the myosin light
chain and dissolution of actin microfilaments. Although the
phosphorylation state of proteins following treatment of mo with PdBu
or dbcAMP has not been examined in this thesis, data presented here
suggest that this would provide useful information relating to the
mechanism by which cytoskeletal architecture is controlled in mo and its
relevance in mo recognition of apoptotic cells.
Specific inhibition of mo phagocytosis of apoptotic neutrophils by mAb
against the av(33 vitronectin receptor (13C2 [av] and 23C6 [avp3]) has
been reported and a direct role for the vitronectin receptor in mo
recognition of apoptotic neutrophils proposed (Savill et al., 1990). This is
in contrast to the findings reported here. It is of interest to note that high
concentrations (1:25) of mAb ascites fluids were used in the inhibition
experiments (Savill et al., 1990) whereas in the experiments described
here, purified mAb was used. It is possible that ascitic fluid contains other
proteins that might affect mo recognition of apoptotic neutrophils (e.g.
other antibodies) and account for these discrepancies. Alternatively, it
may be that when used at high concentrations these mAb may inhibit
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adhesion events which may, in turn, alter cytoskeletal structure. In
addition, a panel of mAb specific for the (33-subunit of the vitronectin
receptor were used in the phagocytosis assay and none of the eight
antibodies had any significant effect on the level of mo phagocytosis of
apoptotic neutrophils. One unlikely possibility is that none of these mAb
bind to functional epitopes on CD61 and thus do not affect mo
phagocytosis. This could be tested by use of these mAb in another assay of
(33 function e.g. JY cell adhesion to vitronectin (Stupack et al., 1992).
Furthermore, the tetrapeptide RGDS, shown previously to inhibit
phagocytosis (Savill et al., 1990), did not alter the amount of phagocytosis
of apoptotic neutrophils in this study. Neither did it cause any change in
the actin staining pattern. Although RGDS was found not to exert
inhibitory effects in this thesis, it is of interest that Werb et al., (1989)
show substantial reorganisation of the actin cytoskeleton of fibroblasts
upon treatment with an RGD containing peptide indicating that RGDS
may also serve to promote de-adhesion events.
The effect of other proposed inhibitors of macrophage phagocytosis of
apoptotic neutrophils on the actin cytoskeleton was also studied. PGE2,
shown in this thesis to reduce the level of phagocytosis, disrupted the mo
actin framework in a manner similar to that seen in dbcAMP treated
cells. Previously, macrophage phagocytosis of apoptotic neutrophils was
described to be dependent on the divalent cations Mg2+ and Ca2+ (Savill
et al., 1990). In this project, EDTA was the most effective inhibitor of mo
phagocytosis of apoptotic neutrophils when included in the phagocytosis
assay, supporting this observation. However, incubation of macrophages
with EDTA was found to have a dramatic effect on the mo actin
cytoskeleton. Savill et al. (1989b), also report that the level of mo
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phagocytosis of apoptotic cells is affected by the pH of the assay medium.
Indeed, initial phagocytosis assays of this thesis were carried out in HBSS
with Ca2+/Mg2+but phagocytosis levels were low (<10%) and this was
attributed to acidification of the HBSS during the course of the assay. To
avoid this problem, the assay medium was changed to Iscove's DMEM.
pH affects the function of gelsolin (Lamb et al., 1993), a calcium-
dependent actin binding protein that binds to the barbed end of actin
filaments and severs actin-actin bonds (Yin et al., 1981). Activation of
gelsolin has been postulated to be involved in receptor-mediated
reorganisation of the actin skeleton. One possibility is that activation of
protein kinases, particularly PKA, alters the function of this actin binding
protein and thus cytoskeletal organisation.
The necessity for cellular energy in mo phagocytosis of apoptotic
neutrophils is demonstrated by complete inhibition when the phagocytic
assay is performed at 4°C. This may demonstrate the requirement for
microfilament structures which are lost following incubation at 4°C
(Kellie et al., 1985). It is likely however that the effect of temperature is
not specific for mo phagocytosis of apoptotic neutrophils but that all
phagocytic events are inhibited at 4°C. Preliminary experiments in which
mo were preincubated with cytochalasin D for 5 minutes resulted in
detachment of the mo from the plate during the phagocytosis assay
making assessment of whether microfilaments are required for
phagocytosis difficult. However, this finding may emphasise the necessity
for intact microfilament networks in maintenance of mo adhesion. In
parallel experiments, phagocytosis of apoptotic neutrophils was
unaffected by pretreatment of mo with the microtubule inhibitor
nocodazole. These results suggest that although an intact actin
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framework is an important factor for mo phagocytosis of apoptotic
neutrophils, microtubule assembly is not required. Furthermore, results
presented here suggest that the adhesion state of the macrophage is an





Phagocytosis of apoptotic neutrophils was found to be modulated by
activating macrophage intracellular protein kinases. Although activation
of mo intracellular protein kinases alters the phenotype of the mo with
respect to the (33 integrin subunit distribution, evidence presented in this
thesis questions the direct involvement of the molecules implicated in
mo phagocytosis of apoptotic neutrophils (Savill et al., 1990 and 1992). An
alternative interpretation of data presented in this thesis and that
previously published by Savill and colleagues is that av(33, CD36 and
thrombospondin are involved indirectly in the process of mo recognition
of apoptotic neutrophils. In support of this, inhibition of mo phagocytosis
of apoptotic cells following dbcAMP treatment was also found to disrupt
the actin cytoskeleton and cause the loss of focal contacts. Indeed, the
cytoskeleton has a major role in controlling cell adhesion (Chong et al.,
1987) and adhesion of macrophages to ECM components has previously
been shown to modulate complement- or immunoglobulin-receptor
mediated phagocytosis (Wright et al., 1983; Pommier et al., 1983; Brown,
1986; Newman and Tucci, 1990).
Historically, the ECM was thought merely to provide an inert scaffold
surrounding cells. More recently, however, it has been realised that the
ECM actively orchestrates key steps in the process of wound healing and
regeneration (Gailit and Clark, 1994; Raghow, 1994). Interactions of cells
with individual components of the ECM can initiate signal transduction
cascades and, as a reservoir of cytokines and growth factors, the ECM can
further modulate a host of cellular responses. It is therefore possible that
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the ECM composition of inflamed sites and thus the adhesive state of the
mo may exert regulatory effects on the process of removal of apoptotic
cells.
In this chapter, I have examined the effects of adhesion of monocyte-
derived macrophages to various ECM proteins upon subsequent
phagocytosis of apoptotic neutrophils. In addition, I have developed a
method for assessment of phagocytosis in suspension to directly address
whether substrate adhesion represents a requirement for mo phagocytosis
of apoptotic neutrophils.
5.2. EFFECT ON PHAGOCYTOSIS OF APOPTOTIC NEUTROPHILS BY
MACROPHAGES ADHERED TO EXTRACELLULAR MATRIX
PROTEINS.
Vitronectin, fibronectin and collagen are components of the extracellular
matrix at different phases of tissue repair (Gailit and Clark (1994). Mo
were therefore adhered to tissue culture wells coated with lOgg/ml
vitronectin, fibronectin, collagen I or collagen VI to assess the effect of
different substrates on mo phagocytosis of apoptotic neutrophils.
Surprisingly, in all cases, the percent of mo phagocytosing apoptotic
neutrophils was found to increase when compared to the level of
phagocytosis in uncoated control wells (Fig. 5.1). The greatest observed
increase (196% of control levels) was for mo plated onto Fn. One
possibility is that some mo which phagocytose apoptotic neutrophils do
not adhere to un-coated plastic and that coating with matrix proteins
allows adhesion of these cells. However, no difference was observed
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Figure 5.1. Modulation of macrophage phagocytosis of apoptotic cells as a
result of adhesion of macrophages to different substrates.
Wells of chamber slides were coated for 18 hours at 4°C with 10pg/ml
vitronectin (VN), fibronectin (FN), collagen I (Col I) and collagen VI (Col
VI) and mo adhered for 60 minutes prior to interaction with apoptotic
neutrophils. Phagocytosis increased by 52.14%, 96.75%, 35.26% and 69.59%
respectively (n=3).
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per field suggesting that the increase in phagocytosis observed is not due
to specific adhesion of phagocytic mo to the ECM proteins. It is also
possible that adhesion to Fn specifically recruits a subpopulation of mo
which are able to phagocytose apoptotic cells or that specific adhesion to
matrix proteins augments mo functional activity in terms of phagocytic
capacity. Thus, the proportion of mo that are able to phagocytose
apoptotic neutrophils is increased.
Integrins have no intrinsic enzyme activity and the mechanism of
signalling mediated by integrins is believed to dependant on their ability
to assemble cytoskeletal frameworks. After binding to ECM components,
integrins bind to the cytoskeleton and promote its reorganisation. The
frameworks formed can influence adhesiveness, cell shape and motility
and may determine how integrin-mediated regulatory signals are
propagated throughout the cell. I therefore analysed the effect of adhesion
to Fn on the mo cytoskeleton. As can be seen in figure 5.2, the actin
framework appears intact with the similar patterns of focal staining as
observed in control and PdBu treated cells.
5.3. EFFECT OF MONOCLONAL ANTIBODIES AGAINST THE
FIBRONECTIN INTEGRIN RECEPTOR ON MACROPHAGE
PHAGOCYTOSIS OF APOPTOTIC NEUTROPHILS.
Since mAb directed against the vitronectin receptor repeatedly failed to
inhibit mo phagocytosis of apoptotic neutrophils and in view of the
observed increase in phagocytic levels for mo adherent to fibronectin, the
effect of mAb against the fibronectin integrin receptor, a5pi, on mo
phagocytosis of apoptotic neutrophils was investigated. For these
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Figure 5.2. Actin distribution of macrophages adhered to fibronectin.
Top panel: Mo, adhered for 60 minutes on glass slides, fixed and stained
with rhodamine-conjugated phalloidin. (Magnification xlOOO).
Lower panel: Mo adhered for 60 minutes on Fn-coated glass slides
(10|ig/ml), fixed and stained with rhodamine-conjugated phalloidin. The
same point structures observed in untreated cells are apparent in mo
adhered to Fn. (Magnification xlOOO).
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experiments I used mAb previously shown to inhibit (31 integrin
function (mAbl3) and a5 function (BIIG2 and SAM-1) and an antibody
which has been demonstrated to increase (31 integrin functional activity
(TS2/16). Mo were incubated for 20 minutes at room temperature with
mAb against the a5- and (31-subunits prior to assessment of ability to
phagocytose apoptotic neutrophils. As can be seen from figure 5.3,
preincubation of the mo with mAb against the fibronectin receptor had
no significant effect on phagocytosis suggesting that ligation of pi
integrins is not involved directly in mo recognition of apoptotic
neutrophils.
Mo were incubated for 30 minutes on ice with 13C2 (1:100; [av]); PM6/13
(1:50; [P3]), BIIG2 (5pg/ml; [a5]) and both 13C2 and PM6/13 prior to
adherence to tissue culture plastic or Fn-coated tissue culture plastic as
described in section 2.7.2ii. Incubation with the mAb had no affect on
adherence of mo to substrate: after 60 minutes at 37°C, mo were observed
to have formed uniform monolayers on both the plastic and Fn-coated
wells. The standard apoptotic neutrophil assay was then performed and
assessed as previously described (section 2.5.2). In this series of
experiments, the neutrophils adhered extensively to the mo in the
PM6/13 treatments making assessment of phagocytosis impossible.
However, incubation of mo with mAb against av or a5 had no effect on
phagocytosis of apoptotic neutrophils under control conditions or on mo
adhered to fibronectin (Fig. 5.4).
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Figure 5.3. Effect of monoclonal antibodies against the a5(31 fibronectin
receptor on macrophage phagocytosis of apoptotic neutrophils.
Mo were incubated for 20 minutes at room temperature with mAb
against the a5- or (31- integrin subunits prior to assessment of their ability
to phagocytose apoptotic neutrophils. Preincubation of mo with these
mAb caused no significant change in phagocytosis levels compared to
control conditions. In this series of experiments, 21.1± 1.9% (mean ± S.E.)
of mo phagocytosed apoptotic neutrophils (n = 3). TS2/16 - (31
stimulatory, mAbl3 - (31 inhibitory, BIIG2 - a5, SAM-1 - a5.
131
250 -i
.......... 1 ^ 1
PLASTIC FIBRONECTIN
SUBSTRATE
Figure 5.4. Effect of incubation of macrophages with monoclonal
antibodies prior to adhesion to substrate on macrophage phagocytosis of
apoptotic neutrophils.
No antibody (black bars), 13C2 (1:100; [av]; grey bars), BIIG2 (5|ig/ml; [a5];
white bars). The hatched bar shows the level of phagocytosis of mo
adhered to Fn as a percent of the plastic control, n = 2.
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5.4. APOPTOTIC NEUTROPHIL PHAGOCYTOSIS ASSAY IN
SUSPENSION.
To determine if the adhesion state of the macrophage was important for
phagocytosis of apoptotic neutrophils, a modified phagocytosis assay was
developed in suspension (as described in section 2.12.1). Mo and
neutrophils were differentially labelled with fluorescent dyes and
incubated together for 30 minutes at either 4°C or 37°C ± EDTA, a protocol
similar to that used to assess cytotoxic T lymphocyte conjugation (Cavarec
et al., 1990). The samples were then analysed by flow cytometry to
determine if there was any interaction between the two cell types: mo (red
positive) were analysed for green fluorescence (apoptotic neutrophils).
Characteristic profiles were obtained for each experimental condition (Fig.
5.5). Three distinct peaks could be identified in all samples, a negative
peak (-ve), a weak positive peak (+) and a strong positive peak (++) (gates
B, C and D respectively in figure 5.5). The experimental condition
appeared to alter the proportion of cells in each peak (Table 5.1). A
standard adherent apoptotic neutrophil phagocytosis assay was performed
in parallel to each suspension assay. Data shown in figure 5.5 and table 5.1
are representative of six separate experiments.
I next considered the interpretation of this data. One possibility was that
the green -ve peak represented mo with no associated neutrophils, the
green ++ peak represented neutrophils adherent to the surface of the mo
while the green + peak represented mo with internalised neutrophils, the
green signal therefore being weaker. In keeping with this, the greatest
proportion of green + cells occurred at 37°C and there were more green
-ve cells at 4°C and in the EDTA treatment (shown to inhibit adherent
mo phagocytosis of apoptotic neutrophils).
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Figure 5.5. Flow cytometric profiles of apoptotic neutrophil phagocytosis
suspension assay.
Mo were labelled with phycoerythrin-conjugated CD14 and apoptotic
neutrophils with CFDA. The two cell types were mixed and incubated
together for 30 minutes at (a) 37°C, (b) 37°C in the presence of 5mM EDTA or
(c) at 4°C before being fixed. The flow cytometer, gated on the red positive
mo, simultaneously analysed for green fluorescence (apoptotic neutrophils).
The profiles are representative of six separate experiments. Gate B = green
-ve cells, gate C = green + cells, gate D = green ++ cells. The proportion of















Proportion of green positive cells (%)
-ve + ++
37°C 46.0 ±0.1 42.7 ± 0.9 11.2 ±1.8
4°C 80.2 ±1.1 14.2 ±1.5 7.1 ± 2.5
EDTA 81.1 ±0.2 14.7 ± 0.2 4.0 ± 0.1
Table 5.1. Flow cytometric analysis of phagocytosis assay performed in
suspension.
The flow cytometry profiles were gated into three distinct areas (shown in
figure 5.4) and the percent of cells in each gate recorded (mean ± S.D. from
duplicate samples). In the standard adherent assay performed in parallel
with the same cells, 33.1 ± 7.2% (mean ± S.D.) of macrophages
phagocytosed apoptotic neutrophils.
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There are a proportion of apoptotic and non-apoptotic cells present in a
population of aged cultured neutrophils. One possibility was that the
green ++ and green + cells represent non-apoptotic and apoptotic cells
respectively. To address this question, the aged non-apoptotic cells were
removed immunomagnetically and the enriched apoptotic population
was used in the suspension assay (as described in section 2.12.2). Similar
profiles were obtained using enriched apoptotic cells (Fig. 5.6) however,
the proportion of -ve and + cells appeared to differ with the population
of neutrophils used, most obviously at 37°C (Table 5.2). The levels of
phagocytosis also increased when the enriched apoptotic neutrophil
population was used in the adherent assay. Similar results were obtained
in a second experiment performed using enriched apoptotic neutrophils.
The increase in the proportion of green + cells at 37°C when an enriched
apoptotic neutrophil population is used, along with the increase in
phagocytosis in the adherent assay, would be in agreement with the
suggested interpretation of the profiles made above. However, when a
similar series of experiments were performed in parallel but with
instantaneous fixation of mo and neutrophils, it was found that a high
proportion of green + cells were present. This raised the possibility that
the high neutrophil/mo ratio used in these experiments was giving false
co-incident signals and that standard flow cytometry does not permit
discrimination of mo and neutrophils at this cell density. However, the
4°C and EDTA data suggest that some resolution of mo and neutrophils
may be achieved. Furthermore, the high proportion of green + cells
present when the assay is performed in the presence of EDTA or at 4°C
suggests that this interpretation is not correct.
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Figure 5.6. Flow cytometric profiles of enriched apoptotic neutrophil
phagocytosis suspension assay.
The same cells were used as in figure 5.5, except the cultured neutrophils
were enriched from 47.5% to 73.8% apoptotic cells, a) 37°C, b) 37°C in the
presence of 5mM EDTA and c) 4°C. The proportion of cells in each gate is





Proportion of green positive cells (%)
-ve + ++
37°C 22.2 ± 0.4 68.4 ± 0.3 9.3 ± 0.1
4°C 68.6 ±8.1 29.6 ± 7.3 1.9 ±1.0
EDTA 60.5 ± 2.2 37.0 ± 2.6 2.2 ±0.1
Table 5.2. Flow cytometric analysis of phagocytosis assay performed in
suspension using enriched apoptotic neutrophils.
The percent of cells from each gate (shown in figure 5.5) are recorded
(mean ± S.D. from duplicate samples). In the standard adherent assay
performed in parallel with the same cells, 49.3 ± 8.0% (mean ± S.D.) of
macrophages phagocytosed the enriched apoptotic neutrophils.
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To resolve these difficulties with the flow cytometric analysis, fluorescent
activated cell sorting was used to separate suspension samples and sorted
fractions were re-analysed by flow cytometry and examination of cytospin
preparations to determine the cell types within each peak. However,
because of the small numbers of mo involved initially, insufficient cells
were obtained at the end of the sort to make analysis possible. Instead, a
magnetic cell sorting method was developed using a MiniMACS
separation unit as described in section 2.12.3ii. The sample loaded onto
the column has a flow cytometric profile in keeping with previous
suspension assays (Fig. 5.7a). Fraction 1 was found to contain a pure
population of aged neutrophils (Fig. 5.7b) and the flow cytometric profile
was identical to that of the cultured neutrophils taken prior to incubation
with mo (not shown). The column was washed twice, fractions 2 and 3
contained aged neutrophils (not shown). The column was then removed
from the magnetic separation unit and washed through a final time. The
eluent (fraction 4) was shown to contain a relatively pure population of
mo. A few of these fraction 4 mo contained apoptotic neutrophils within
cytoplasmic vacuoles (Fig. 5.7c). The flow cytometric profile of fraction 4
was very different to the original sample loaded onto the column (Fig.
5.7a) but similar to the profile obtained for mo prior to the phagocytosis
assay (data obtained from mo flow cytometry profile is quoted in Fig. 5.7c).
Although phagocytosis was observed in suspension samples, the
proportion of mo ingesting neutrophils was reduced when compared to
the adherent assay, phagocytosis in suspension is less than one fifth of
that observed in adherent cells (table 5.3). This reduced phagocytosis was
not a result of manipulation of the cells in vitro as phagocytosis levels
were still as markedly reduced in experiments where handling of the cells
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Figure 5.7. (a) Flow cytometric profile and photograph of suspension assay
sample loaded onto miniMACS separation column.
Mo and cultured neutrophils, incubated together for 30 minutes in
suspension at 37°C, were loaded onto a miniMACS separation column
placed in a miniMACS separation unit. The sample has a flow cytometric
profile typical of previous experiments. Proportion of cells in each peak:
91.6% green -ve cells; 8.2% green + cells; 0.2% green ++ cells.
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Figure 5.7. (b) Flow cytometric profile and photograph of fraction 1
collected from miniMACS separation column.
Fraction 1 is seen to contain a pure population of cultured neutrophils. The
flow cytometric profile of fraction 1 matches that of the cultured neutrophils
used in the assay.
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Figure 5.7. (c) Flow cytometric profile and photograph of fraction 4
collected from miniMACS separation column.
The sample can be seen to contain a purified population of mo, one of which
has a cytoplasmic vacuole containing an apoptotic neutrophil (arrow). Some
non-phagocytosed neutrophils are also present. Porportion of cells in each
peak: 98.9% green -ve cells; 1.1% green + cells; 0% green ++ cells.
(Proportion of cells in each peak from mo sample prior to phagocytosis
assay: 99.6% green -ve cells; 0.4% green + cells; 0% green ++ cells).
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Table 5.3. Summary of results obtained from the phagocytosis assays
performed in suspension.
§ - counted from cytospin preparations of purified fraction 4 from
miniMACS separation column except for experiments 9 and 10 in which
results were compared between suspension assay (top values) and fraction 4
from the miniMACS column (bottom value)
a - mean ± S.D. of duplicate samples except experiments 9 and 10 (single
samples)
*
- experiments in which the aged neutrophil populations (top values) were
enriched for apoptotic cells (bottom values)














































































was kept to a minimum (2.12.3ii). Neither was it a consequence of the
labelling protocol as cells used in the parallel adherent assays were also
labelled. Table 5.3 shows a summary of all results obtained for this thesis
of the phagocytic suspension assays performed at 37°C.
5.5. SUMMARY OF RESULTS.
Adhesion of mo to ECM components, notably fibronectin, increases
phagocytosis of apoptotic neutrophils. However, mAb studies suggest that
the a5(3l fibronectin receptor alone is not involved in either recognition
of apoptotic neutrophils or mo adhesion to fibronectin. Execution of the
apoptotic neutrophil phagocytosis assay in suspension results in
comparatively low levels of phagocytosis in relation to parallel adhesive
assays implying that the adhesion state of the mo is an important factor
in the modulation of apoptotic neutrophil phagocytosis.
5.6. DISCUSSION.
The composition, structure and functional heterogeneity of the
extracellular matrix depends on tissue origin and stage of development.
However, most ECM contain a backbone of fibrillar proteins (collagen)
into which a variety of glycoproteins, carbohydrates and proteoglycans are
enmeshed. Vitronectin is a multifunctional glycoprotein found in tissues
and plasma. Recognised as an adhesive substrate, cell interaction with Vn
may induce spreading and migration and have an effect on cell growth
and differentiation in processes such as tumour growth and metastasis,
wound healing, bone resorption and viral infection (Preissner, 1991;
Felding-Habermann and Cheresh, 1993). Fibronectin is a widespread ECM
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and body fluid glycoprotein involved in embryogenesis, wound healing,
haemostasis and thrombosis. It is the best studied adhesive protein
component of the ECM involved in cell adhesion and chemotaxis
(Ruoslahti, 1988; Potts and Campbell, 1994). Collagen is the most
abundant protein, accounting for approximately one third of total body
proteins. It is the major structural protein, holding cells together and
giving organs their characteristic architecture (Gordon and Olsen, 1990).
Results in this chapter suggest that adhesion of monocyte-derived
macrophages to ECM components enhances phagocytosis of apoptotic
neutrophils in relation to control conditions, most significantly when
adhered to Fn. Macrophages themselves are a source of ECM components
and matrix deposition by mo in vitro might account for the variation of
the levels of phagocytosis observed as a consequence of mo donor
heterogeneity.
A previous study (Savill et al., 1990) has described inhibition of apoptotic
neutrophil phagocytosis when macrophages were adherent to Fn and Vn.
One possible explanation for these apparently contradictory results is the
higher concentration of ECM protein (80pg/ml) used by Savill et al.
(1990). It has been shown that the number of ligand-receptor contacts is a
important factor in regulating cell adhesion (Massia and Hubbell, 1991). It
is therefore possible that the levels of expression of ECM components
may exert different effects upon mo phagocytosis of apoptotic neutrophils
in a manner similar to the effects of chemotractants which typically
inhibit migration at high concentrations. At low levels of ECM
components, adhesion and migration may be promoted whereas at
higher concentrations, migration may be inhibited. Of interest are the
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results from a preliminary experiment carried out for this thesis in which
mo were adhered to different concentrations of Fn. Phagocytosis levels
fell with increasing concentrations of Fn The percent of mo adhered to
80(ig/ml Fn phagocytosing apoptotic neutrophils was found to be the
same as mo adhered to tissue culture plastic. While further experiments
are necessary to uphold this result, the initial data would tend to support
the possibility discussed above.
Vn is an early and transient component of the ECM in wound repair
while Fn expression persists throughout the entire process (Clark, 1990;
Gailit and Clark, 1994). Intact Vn and Fn can also be detected in acute
wound fluid (Grinnell et al., 1992). The observation that phagocytosis of
apoptotic neutrophils is enhanced upon adhesion of mo to ECM proteins
that are present in wounds at a time when neutrophils would be
removed from damaged tissue is of great significance in terms of
composition of the ECM and the resolution of inflammation. On the
other hand, wound fluid from chronic inflammation contains degraded
polypeptides of ECM components which have been shown to have an
inhibitory effect on cellular adhesion (Grinnell et al., 1992). In view of
this, it would be of value to assess the effects of degraded ECM
polypeptides upon mo phagocytosis of apoptotic neutrophils.
Perturbation of apoptotic neutrophil phagocytosis by mo in the presence
of degraded ECM might be associated with disease pathogenesis and also
account for the persistence of chronic inflammation. The composition of
the ECM may therefore provide an additional level of control for the rate
at which apoptotic neutrophils are removed.
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In terms of cytoskeletal organisation, mo adherent to Fn appear to have
an intact actin cytoskeleton. It has recently been reported that
macrophages adhered to Fn-coated wells for 30 minutes show a decrease
in filamentous actin content (Yang et al., 1994). However, results were
obtained by flow cytometric analysis and it is therefore not known to
what extent the actin framework was disrupted. Also it is possible that
further time points, beyond 30 minutes, might have shown a return to
resting levels. Interestingly, a preliminary experiment in which mo were
adhered to Fn and treated for 15 minutes with dbcAMP prior to the
apoptotic neutrophil assay, showed a decrease in phagocytic levels when
compared to untreated mo adhered to Fn. Further experiments will be
required to verify this initial observation and it will be of interest to
investigate the effect of dbcAMP on the actin cytoskeleton of mo adhered
to Fn.
Integrins are the major receptors involved in cell-matrix interactions. As
adhesion of mo to fibronectin enhanced apoptotic neutrophil
phagocytosis, a role for the fibronectin integrin receptor, a5(3l, in mo
phagocytosis of apoptotic neutrophils was investigated. TS2/16 is an anti-
pi mAb, shown to up regulate pi -integrin mediated cell attachment to
different ligands (Arroyo et al., 1992) by inducing an high affinity state of
pi integrins by directly changing the receptor conformation (Arroyo et al.,
1993). In contrast, mAbl3 is an anti-pi mAb that inhibits early cellular
binding to ECM (Berdichevsky et al., 1992). BIIG2 is an adhesion blocking
mAb against the a5-subunit of the fibronectin receptor that interferes
with the initial attachment of many cell types to Fn but not to Col I, Col
IV or Vn (Werb et al., 1989). SAM-1, directed against the a5-subunit, has
been reported to block the uptake of apoptotic B-cells (Flora and Gregory,
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1993). No significant effect was observed upon mo phagocytosis of
apoptotic neutrophils as a result of preincubating mo with mAb against
a5(3l suggesting that the a5(3l fibronectin receptor is not involved mo
phagocytosis of apoptotic neutrophils. Nor does it appear that mo are
adhering to substrate (tissue culture plastic or Fn-coated plastic) via the
av(33 or a5(3l receptors as incubation of mo with mAb against the a-
subunit of these receptors prior to substrate adhesion did not affect the
number of cells viewed per microscope field or the subsequent level of
phagocytosis of apoptotic neutrophils. However, mo have multiple
receptors that promote adhesion to Fn and it is possible that blocking one
receptor merely induces the cell to utilise another adhesion pathway.
Studies in which all mo Fn receptors are blocked simultaneously may
allow this possibility to be tested.
The relatively low levels of phagocytosis observed in the suspension
assay suggest that adhesion to substrate is a major requirement for mo
phagocytosis of apoptotic neutrophils. It would be of interest to
investigate if pretreatment of suspension mo with PdBu or addition of
ECM components to the suspension assay (both methods shown to
enhance phagocytosis of apoptotic neutrophils in adherent assays)
enhanced the low levels of phagocytosis observed. In addition, the
integrity of the actin filament network is required for cell locomotion
(Bearer, 1993; Stossel, 1993). Secondary to altered cellular adhesion may be
the effect on mo motility. Indeed, the organisation of cytoskeletal
components within mo observed for this thesis is consistent with the
presence of motile cells. Thus mo phagocytic responses may reflect a
combined requirement for cell adhesivity and cell motility.
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CHAPTER 6: SUMMARY.
This thesis has focused upon the model of macrophage recognition and
phagocytosis of apoptotic neutrophils proposed by Savill et al. (1992) with
the aim of defining mechanisms that modulate this phagocytic process.
Apoptosis is the mechanism by which cells are physiologically deleted from
a wide variety of tissues, apoptotic cells being taken up by surrounding
resident tissue cells (Wyllie et al., 1980) or macrophages (Savill et al., 1989a;
Jones et al., 1993). In the multicellular organism C. elegans, in which 131 cells
die by apoptosis during development, recognition and phagocytosis of
apoptotic bodies involves at least 10 gene products, ced-3 and ced-4 induce
cell death, ced-9 is crucial for prevention of apoptosis while seven genes (ced-
1, ced-2, ced-5, ced-6, ced-7, ced-8 and ced-10) contribute to engulfment of
apoptotic cells (Driscoll, 1992). Given the homologies between invertebrate
and mammalian systems in terms of the machinery that regulates cell death
e.g. ced-3 and ICE (Lazebink et al., 1994) and ced-9 and bcl-2 (Hengartner and
Horvitz, 1994), it is likely that many of the genes involved in engulfment of
apoptotic cells in C. elegans will have a similar role in mammalian systems.
Thus, the molecular mechanisms by which apoptotic cells are recognised and
phagocytosed in mammalian systems may also be complex and involve
multiple gene products.
In addition to the characteristic morphological and biochemical changes of
apoptosis, specific membrane changes have been described including
glycosylation changes (Duvall et al., 1985), altered membrane lipid
asymmetry (Fadok et al., 1992a) and reduction in expression of cell surface
receptors (Dransfield et al., 1994: Homberg et al., 1995). Expression of
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phosphatidylserine on the outer leaflet of the plasma membrane has been
suggested to occur during apoptosis and has been reported to be involved in
macrophage phagocytosis of apoptotic cells (Fadok et ah, 1992a). The surface
molecule on apoptotic neutrophils that signals macrophage recognition is as
yet unknown. However, apoptotic neutrophil recognition by mo has been
found to be charge sensitive at the neutrophil surface, as indicated by
inhibition in the presence of amino sugars and basic amino acids.
Characterisation of the surface of apoptotic cells may define molecules
involved in providing phagocytic signals to mo and perhaps reveal further
novel mechanisms of recognition.
To date, three mechanisms have been described for phagocytosis of
apoptotic neutrophils by macrophages. Savill and co-workers have defined a
human system that involves the macrophage avp3 vitronectin receptor and
CD36 acting in concert to bind thrombospondin which serves as a molecular
bridge between the macrophage and apoptotic cell (Savill et ah, 1990 and
1992). In a murine system, Fadok et ah (1992b) suggest that the mechanism
by which macrophages recognise apoptotic neutrophils is determined by the
subpopulation of macrophages being studied. They show that murine
peritoneal macrophages utilise a phosphatidylserine dependent mechanism
for the phagocytosis of apoptotic neutrophils whereas murine bone marrow
macrophages, like human monocyte-derived macrophages, employ the
vitronectin receptor (Fadok et ah, 1992b). Most recently, Flora and Gregory
(1994) describe macrophage phagocytosis of apoptotic cells via a 61D3
antigen-dependent pathway distinguishable from the avP3-dependent
mechanism. However, the mechanism used for recognition of apoptotic cells
was found to be dependent on the macrophage donor: A-type donors cells
utilised both the 61D3- and av[33-dependent pathways to recognise
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apoptotic cells while B-type donors were only able to employ the 61D3-
dependent mechanism. However, in all of the mechanisms described above,
total inhibition of phagocytosis has never been shown suggesting the
potential for further phagocytic pathways, distinct from those described
above.
Although "professional" phagocytes such as macrophages are able to
efficiently remove apoptotic cells, the role of stromal cells in this process has
received relatively little study. Recently, Hall et al. (1994) have reported that
fibroblasts recognise apoptotic neutrophils. Two distinct mechanisms appear
to be involved: one utilising av(33, the other employing a mannose/fructose-
specific lectin which plays no part in phagocytosis of the apoptotic cell.
Interaction between fibroblasts and apoptotic neutrophils may be of
relevance to the relationship between inflammation and scarring associated
with disease.
It is well documented that macrophages do not recognise and phagocytose
freshly isolated neutrophils (Newman et al., 1982; Savill et al., 1989a) but that
macrophage recognition of neutrophils progressively increases with time in
culture. Morphological changes characteristic of apoptosis were observed in
aged neutrophil populations and a highly significant correlation between
recognition and apoptosis was found. Consequently, apoptosis in the aged
neutrophil population was directly linked to recognition by mo (Savill et al.,
1992a). However, it has recently been reported that phagocytosis of aged
neutrophils occurs independently of apoptosis. The oncogene bcl-2, has been
shown to block the molecular processes of cell death (Vaux et al., 1988). Over
expression of Bcl-2, which may be localised to the inner mitochondrial
membrane, promotes cell survival without promoting cellular division
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(Hockenbery et al., 1990) indicating its critical role in regulation of cell death
in some systems. Lagasse and Weissman (1994) found that while induced
bcl-2 expression in mature neutrophils inhibited apoptosis, phagocytosis of
the aged cells still took place. They propose that neutrophils exhibit cell
surface changes, independent of apoptosis, that enable recognition and
engulfment by macrophages. Since this model is based on a murine system,
comparison with the removal of human cells is difficult and the mechanism
by which macrophages ingested bcl-2 expressing non-apoptotic neutrophils
was not discussed. However, it is likely that in the future, such model
systems will provide useful molecular information as to how apoptotic cells
are recognised.
Phagocytosis of apoptotic neutrophils by macrophages represents a non¬
inflammatory mechanism for the removal of senescent cells from inflamed
sites. In view of the capacity of many granule contents to cause tissue injury
(Weiss, 1989) and cleave tissue matrix proteins into chemotactic fragments
(Vartio, 1981), necrotic neutrophil cell death would tend to damage healthy
tissues and exacerbate inflammatory processes. However, during apoptosis,
membrane integrity is preserved (Savill et al., 1989a) and neutrophil
functions, including granule secretion, are markedly down-regulated (Whyte
et al., 1993b) thus limiting the potential for neutrophil-mediated tissue
damage. Furthermore, phagocytosis of apoptotic neutrophils via the
av(33/CD36 recognition mechanism does not induce the release of pro¬
inflammatory macrophage mediators such as thromboxane B2 or N-acetyl-j3-
D-glucosaminidase (Meagher et al., 1992). Therefore, modulation of this
phagocytic event may limit tissue injury and promote the normal resolution
process in inflammation.
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Integrin function has been shown to be modulated by protein kinase
activation (Dustin and Springer, 1989: Shimizu et al., 1990: Stupack et al.,
1992). The av(33 integrin has been implicated in macrophage recognition of
apoptotic neutrophils (Savill et al., 1990) therefore initial work in this thesis
involved short pretreatment of monocyte-derived macrophages with
activators of protein kinase C and A to assess their effect on phagocytosis of
apoptotic neutrophils. I have shown that activation of intracellular protein
kinases alters the phagocytic potential of mo for apoptotic neutrophils.
Activation of PKC enhanced mo recognition of apoptotic neutrophils while
PKA activation caused down regulation of recognition. Inflammatory
mediators have multiple effects upon leukocyte function however, those that
stimulate PKC activity may increase apoptotic cell removal from inflamed
sites. Interestingly, preincubation of day four mo with 'proinflammatory'
cytokines e.g. GMCSF or LPS for six hours has been found to enhance
apoptotic neutrophil phagocytosis (Ren and Savill, personal communication)
although the mechanism by which phagocytosis is modulated is not yet
known. It is thought that the capacity of cytokines (which tend to promote
inflammation by recruitment of leukocytes to inflamed sites) to promote
resolution by increasing the ability of mo to remove apoptotic cells may
represent a form of negative feedback controlling inflammation.
Throughout the course of my investigations, I have found no evidence to
support the model proposed by Savill et al. (1990 and 1992) implicating a
direct interaction of av|33, CD36 and thrombospondin with the apoptotic
neutrophil. However, it is likely that there are indirect associations that
modulate macrophage phagocytic responses. Thrombospondin could not be
detected from macrophage supernatants and CD36 mAb inhibition studies
reveal additional complexities that require further study (Dransfield et al.,
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1995). Furthermore, in a series of blocking experiments, a panel of mAb
against the vitronectin receptor a- and (3-subunits did not reduce the
proportion of mo able to phagocytose apoptotic neutrophil. In previous mAb
studies, reduction of mo phagocytosis of apoptotic was reported using high
concentrations (1:25) of mAb ascites fluid (Savill et al., 1990, 1992). In this
thesis, purified mAb were used and no significant reduction of mo
phagocytosis of apoptotic neutrophils was observed. There are several
problems which may be associated with use of high concentrations of mAb.
First, there may be specific receptor cross-linking that may result in
activation of intracellular signalling pathways that subsequently modulate
cellular function. As I have demonstrated in this thesis, elevation of
intracellular cAMP in mo exerts an inhibitory effect on mo recognition of
apoptotic cells. Alternatively, receptor cross-linking may cause
internalisation of receptors which may also modulate cellular behaviour. An
additional complication is that the use of whole antibody may co-cross-link
specific receptors and Fc receptors present on the mo surface (via the Fc
portion of antibody), again possibly activating intracellular pathways. One
approach which would bypass these problems is the use of Fab' fragments of
inhibitory antibodies thereby avoiding both cross-linking effects and
possible engagement of Fc receptors. Furthermore, as noted in chapter four,
ascitic fluid may also contain other proteins e.g. matrix molecules that might
affect mo recognition of apoptotic neutrophils.
I therefore considered whether the av(33 receptor might affect phagocytosis
indirectly. Integrins are capable of transducing signals from the exterior of
the cell to the interior and also altering cytoskeletal architecture as a result of
their association with the cytoskeleton. Altered distribution of avP3
following protein kinase activation (described in section 3.8) may exert
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indirect control over the process of mo phagocytosis of apoptotic
neutrophils, possibly via the macrophage actin cytoskeleton. Although av|33
could not be seen to localise with the focal contacts present in mo, it is
possible that av(33 is associated with less well defined structures within the
actin cytoskeleton. While not ruling out a role for avp3,1 believe the role of
the vitronectin receptor in macrophage phagocytosis of apoptotic
neutrophils needs to be reviewed. The use of Fab' fragments of antibody and
perhaps avP3 negative cell lines may allow the role of avP3 in phagocytosis
of apoptotic neutrophils to be re-assessed. Savill and colleagues have
recently demonstrated CD36 transfected melanoma cells phagocytose
apoptotic neutrophils. Transfection of avP3 negative melanoma cell lines
with CD36 may provide an alternative strategy for examining the role of
avP3.
A variety of agents, including dbcAMP, that inhibited apoptotic neutrophil
phagocytosis were also found to disrupt the mo actin framework. The actin
cytoskeleton is an integral part of the cell adhesion process and in
subsequent experiments, mo adherent to ECM proteins were found to be
more efficient phagocytes of apoptotic neutrophils suggesting that the
adhesion state of the mo is an important regulatory factor in mo
phagocytosis of apoptotic cells. This is supported by the results obtained
when the phagocytosis assay was performed in suspension - the mean
phagocytosis level in suspension is only 13% of that observed in adherent
assays.
In conclusion, work presented in this thesis has addressed mechanisms
involved in modulating the capacity of macrophages to recognise and
phagocytose apoptotic neutrophils. Taken together, these data support a
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model for macrophage recognition of apoptotic neutrophils in which the
adhesion state of the macrophage is an important regulatory factor (Fig. 6.1).
No evidence has been obtained for a direct role of av(33 in apoptotic
neutrophil recognition which may indicate that this receptor exerts a
regulatory effect indirectly. Indeed, av[33 mediates adhesion to a variety of
substrates, including fibronectin and thrombospondin. Integrin adhesion
may modulate cellular behaviour via initiation of intracellular signalling
pathways and it is possible that the av(33 may act as a regulator of apoptotic
neutrophil recognition mechanisms. I have demonstrated that rapid
modulation of the macrophage potential for apoptotic cell removal is
achieved by activation of intracellular protein kinases. This effect is, in part,
achieved by alteration of the architecture of the macrophage actin
cytoskeleton and thus the adhesive state of the macrophage itself. Since the
extracellular matrix components produced at inflamed sites are altered
during the progression of wound healing responses, I would hypothesise
that the precise composition of the extracellular environment encountered by
macrophages regulates their ability to recognise and phagocytose apoptotic
cells. Thus, macrophage responses to mediators of inflammation and
peturbation of normal matrix deposition during inflammatory responses
may be important factors in determining the process of resolution of
inflammation and disease pathogenesis.
162
Figure 6.1. Proposed model for modulation of macrophage phagocytosis of
apoptotic neutophils.
Phagocytosis of apoptotic neutrophils by monocyte-derived macrophages
was found to be modulated by short term pre-treatment of mo with
activators of PKC and PKA. Localised [53 distribution is associated with
activation of PKC, however, no evidence has been obtained for a direct role
of av[53 in apoptotic neutrophil recognition and although not found to
localise to focal contacts, av(53 may act as a regulator of apoptotic neutrophil
recognition mechanisms via initiation of intracellular signalling pathways.
Activation PKA was seen to cause disruption of the macrophage actin
cytoskeleton. Adherence of macrophages to extracellular matrix proteins was
found to increase levels of phagocytosis compared to control conditions. By
contrast, very little phagocytosis was observed when the assay was
performed in suspension. These data suggest that the adhesion state of the
macrophage is important in regulating phagocytosis of apoptotic neutrophils
and that the tissue micro-environment of the macrophage at inflammed sites
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